ChampionX Corp - Quarter Report: 2022 June (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 001-38441
ChampionX Corporation
(Exact name of registrant as specified in its charter)
Delaware | 82-3066826 | ||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||
2445 Technology Forest Blvd, | Building 4, 12th Floor | ||||||||||
The Woodlands, | Texas | 77381 | |||||||||
(Address of principal executive offices) | (Zip Code) |
(281) 403-5772
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common stock, $0.01 par value | CHX | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☑ | Accelerated filer | ☐ | |||||||||||
Non-accelerated filer | ☐ | Smaller reporting company | ☐ | |||||||||||
Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑
The registrant had 202,932,903 shares of common stock, $0.01 par value, outstanding as of July 21, 2022.
CHAMPIONX CORPORATION
TABLE OF CONTENTS
Page | ||||||||
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this report are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements usually relate to future events and anticipated revenues, earnings, cash flows or other aspects of our operations or operating results. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. The absence of these words, however, does not mean that the statements are not forward-looking statements. Forward-looking statements are based on our current expectations, beliefs and assumptions concerning future developments and business conditions and their potential effect on us. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate.
All of our forward-looking statements involve risks, uncertainties (some of which are significant or beyond our control) and assumptions that could cause actual results to materially differ from our historical experience and our present expectations or projections. Known material factors that could cause actual results to materially differ from those contemplated in the forward-looking statements are those set forth in Part I, Item 1A, “Risk Factors,” of our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 and in Part II, Item 1A, “Risk Factors,” in this Quarterly Report on Form 10-Q, including the following:
•Demand for, and profitability of our products and services, is affected by changes in the price of, and demand for, crude oil and natural gas in domestic and international markets;
•Cost inflation and availability of raw materials;
•The impact of inflation in wholesale product costs, labor rates and transportation costs
•Our ability to successfully compete with other companies in our industry;
•Our ability to develop and implement or introduce new technologies, products, and services, as well as our ability to protect and maintain critical intellectual property assets;
•Our ability to successfully execute potential acquisitions;
•Potential liabilities arising out of the installation or use of our products or from a chemical spill or release;
•Continuing consolidation within our customers’ industry;
•Credit risks related to our customer base or the loss of significant customers;
•A failure of our information technology infrastructure or any significant breach of security;
•Risks relating to our existing international operations and expansion into new geographical markets;
•Risks relating to improper conduct by any of our employees, agents or business partners;
•Global economic conditions, inflation, geopolitical issues, supply chain disruptions, and availability and cost of credit, and its impact on our operations and those of our customers and suppliers;
•Failure to attract, retain and develop personnel;
•Our ability to protect or obtain intellectual property rights;
•The impact of natural disasters and other unusual weather conditions on our business;
•The impact of the novel coronavirus (“COVID-19”) and related economic disruptions;
•Investor sentiment towards climate change, fossil fuels and other environmental, social and governance matters;
•Changes in domestic and foreign governmental public policies, risks associated with entry into emerging markets, changes in statutory tax rates and unanticipated outcomes with respect to tax audits;
•Disruptions in the political, regulatory, economic and social conditions of the countries in which we conduct business;
•Fluctuations in currency markets worldwide and disruptions in capital and credit markets;
•The impact of our indebtedness on our financial position and operating flexibility;
•Our ability to realize the benefits of the acquisition of our Chemical Technologies business, and certain limitations in our ability to engage in certain activities as a result of that acquisition;
•The impact of war, terrorism and civil unrest;
•Changes in federal, state and local legislation and regulations relating to oil and gas development and the potential for related litigation or restrictions on our customers;
•Changes in environmental and health and safety laws and regulations which may increase our costs, limit the demand for our products and services or restrict our operations; and
•The impact of tariffs and other trade measures on our business.
We wish to caution you not to place undue reliance on any forward-looking statements, which speak only as of the date hereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws.
PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
CHAMPIONX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(in thousands, except per share data) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Revenue: | |||||||||||||||||||||||
Product revenue | $ | 807,553 | $ | 649,399 | $ | 1,558,221 | $ | 1,234,756 | |||||||||||||||
Service revenue | 101,843 | 81,223 | 198,237 | 161,849 | |||||||||||||||||||
Lease and other revenue | 23,176 | 18,550 | 42,074 | 37,455 | |||||||||||||||||||
Total revenue | 932,572 | 749,172 | 1,798,532 | 1,434,060 | |||||||||||||||||||
Cost of goods and services | 720,684 | 569,167 | 1,379,034 | 1,091,723 | |||||||||||||||||||
Gross profit | 211,888 | 180,005 | 419,498 | 342,337 | |||||||||||||||||||
Costs and expenses: | |||||||||||||||||||||||
Selling, general and administrative expense | 141,351 | 152,341 | 291,711 | 295,819 | |||||||||||||||||||
Interest expense, net | 10,765 | 14,064 | 22,128 | 28,035 | |||||||||||||||||||
Other (income) expense, net | 32,281 | 2,251 | 33,601 | 315 | |||||||||||||||||||
Income before income taxes | 27,491 | 11,349 | 72,058 | 18,168 | |||||||||||||||||||
Provision for (benefit from) income taxes | (1,405) | 3,563 | 4,989 | 6,345 | |||||||||||||||||||
Net income | 28,896 | 7,786 | 67,069 | 11,823 | |||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interest | 1,554 | 536 | 3,025 | (1,199) | |||||||||||||||||||
Net income attributable to ChampionX | $ | 27,342 | $ | 7,250 | $ | 64,044 | $ | 13,022 | |||||||||||||||
Earnings per share attributable to ChampionX: | |||||||||||||||||||||||
Basic | $ | 0.13 | $ | 0.04 | $ | 0.32 | $ | 0.06 | |||||||||||||||
Diluted | $ | 0.13 | $ | 0.03 | $ | 0.31 | $ | 0.06 | |||||||||||||||
Weighted-average shares outstanding: | |||||||||||||||||||||||
Basic | 203,322 | 201,467 | 203,200 | 201,063 | |||||||||||||||||||
Diluted | 208,714 | 208,541 | 208,863 | 207,939 | |||||||||||||||||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
1
CHAMPIONX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Net income | $ | 28,896 | $ | 7,786 | $ | 67,069 | $ | 11,823 | |||||||||||||||
Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
Foreign currency translation adjustments | 21,169 | 8,332 | 19,604 | 11,545 | |||||||||||||||||||
Cash flow hedges | (3,403) | (277) | (4,702) | 136 | |||||||||||||||||||
Defined pension and other post-retirement benefits adjustments, net | 70 | 6,373 | 139 | 6,540 | |||||||||||||||||||
Other comprehensive income | 17,836 | 14,428 | 15,041 | 18,221 | |||||||||||||||||||
Comprehensive income | 46,732 | 22,214 | 82,110 | 30,044 | |||||||||||||||||||
Less: Comprehensive income (loss) attributable to noncontrolling interest | 1,554 | 536 | 3,025 | (1,199) | |||||||||||||||||||
Comprehensive income attributable to ChampionX | $ | 45,178 | $ | 21,678 | $ | 79,085 | $ | 31,243 |
The accompanying notes are an integral part of the condensed consolidated financial statements.
2
CHAMPIONX CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(in thousands) | June 30, 2022 | December 31, 2021 | |||||||||
ASSETS | |||||||||||
Current Assets: | |||||||||||
Cash and cash equivalents | $ | 167,282 | $ | 251,678 | |||||||
Restricted cash | 3,500 | 3,500 | |||||||||
Receivables, net | 614,607 | 584,440 | |||||||||
Inventories, net | 606,956 | 542,910 | |||||||||
Assets held for sale | 25,455 | 7,217 | |||||||||
Prepaid expenses and other current assets | 52,116 | 71,155 | |||||||||
Total current assets | 1,469,916 | 1,460,900 | |||||||||
Property, plant and equipment, net of accumulated depreciation of $646,795 in 2022 and $618,867 in 2021 | 746,408 | 776,813 | |||||||||
Goodwill | 724,398 | 702,867 | |||||||||
Intangible assets, net | 351,374 | 401,470 | |||||||||
Operating lease right-of-use assets | 101,350 | 115,458 | |||||||||
Other non-current assets | 69,705 | 77,193 | |||||||||
Total assets | $ | 3,463,151 | $ | 3,534,701 | |||||||
LIABILITIES AND EQUITY | |||||||||||
Current Liabilities: | |||||||||||
Current portion of long-term debt | $ | 4,688 | $ | 26,850 | |||||||
Accounts payable | 496,197 | 473,561 | |||||||||
Accrued compensation and employee benefits | 54,864 | 93,131 | |||||||||
Current portion of operating lease liabilities | 32,438 | 36,389 | |||||||||
Accrued distributor fees | 35,166 | 25,621 | |||||||||
Liabilities held for sale | 10,428 | — | |||||||||
Accrued expenses and other current liabilities | 119,252 | 146,773 | |||||||||
Total current liabilities | 753,033 | 802,325 | |||||||||
Long-term debt | 694,430 | 697,657 | |||||||||
Deferred income taxes | 84,709 | 137,971 | |||||||||
Operating lease liabilities | 64,138 | 73,521 | |||||||||
Other long-term liabilities | 73,986 | 68,920 | |||||||||
Total liabilities | 1,670,296 | 1,780,394 | |||||||||
Stockholders’ equity: | |||||||||||
Common stock (2.5 billion shares authorized, $0.01 par value) 202.9 million shares and 202.9 million shares issued and outstanding in 2022 and 2021, respectively | 2,029 | 2,029 | |||||||||
Capital in excess of par value of common stock | 2,315,965 | 2,315,399 | |||||||||
Accumulated deficit | (503,089) | (525,158) | |||||||||
Accumulated other comprehensive loss | (6,584) | (21,625) | |||||||||
ChampionX stockholders’ equity | 1,808,321 | 1,770,645 | |||||||||
Noncontrolling interest | (15,466) | (16,338) | |||||||||
Total equity | 1,792,855 | 1,754,307 | |||||||||
Total liabilities and equity | $ | 3,463,151 | $ | 3,534,701 |
The accompanying notes are an integral part of the condensed consolidated financial statements.
3
CHAMPIONX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(Unaudited)
Common Stock | |||||||||||||||||||||||||||||||||||||||||
(in thousands) | Shares | Par Value | Capital in Excess of Par Value | Accum. Deficit | Accum. Other Comp. Loss | Non-controlling Interest | Total | ||||||||||||||||||||||||||||||||||
December 31, 2021 | 202,866 | $ | 2,029 | $ | 2,315,399 | $ | (525,158) | $ | (21,625) | $ | (16,338) | $ | 1,754,307 | ||||||||||||||||||||||||||||
Net income | — | — | — | 36,702 | — | 1,471 | 38,173 | ||||||||||||||||||||||||||||||||||
Other comprehensive loss | — | — | — | — | (2,795) | — | (2,795) | ||||||||||||||||||||||||||||||||||
Stock-based compensation | 290 | 3 | 4,725 | — | — | — | 4,728 | ||||||||||||||||||||||||||||||||||
Stock options exercised | 189 | 1 | 1,054 | — | — | — | 1,055 | ||||||||||||||||||||||||||||||||||
Taxes withheld on issuance of stock-based awards | — | — | (2,639) | — | — | — | (2,639) | ||||||||||||||||||||||||||||||||||
Dividends declared to common stockholders ($0.075 per share) | — | — | — | (15,465) | — | — | (15,465) | ||||||||||||||||||||||||||||||||||
Cumulative translation adjustments | — | — | — | — | — | 208 | 208 | ||||||||||||||||||||||||||||||||||
March 31, 2022 | 203,345 | $ | 2,033 | $ | 2,318,539 | $ | (503,921) | $ | (24,420) | $ | (14,659) | $ | 1,777,572 | ||||||||||||||||||||||||||||
Net income | — | — | — | 27,342 | — | 1,554 | 28,896 | ||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | 17,836 | — | 17,836 | ||||||||||||||||||||||||||||||||||
Stock-based compensation | 64 | 1 | 5,070 | — | — | — | 5,071 | ||||||||||||||||||||||||||||||||||
Stock options exercised | 312 | 3 | 2,087 | — | — | — | 2,090 | ||||||||||||||||||||||||||||||||||
Taxes withheld on issuance of stock-based awards | — | — | (739) | — | — | — | (739) | ||||||||||||||||||||||||||||||||||
Dividends declared to common stockholders ($0.075 per share) | — | — | — | (15,494) | — | — | (15,494) | ||||||||||||||||||||||||||||||||||
Repurchase and cancellation of common stock | (790) | (8) | (8,992) | (11,016) | — | — | (20,016) | ||||||||||||||||||||||||||||||||||
Cumulative translation adjustments | — | — | — | — | — | 8 | 8 | ||||||||||||||||||||||||||||||||||
Distributions to noncontrolling interest | — | — | — | — | — | (2,369) | (2,369) | ||||||||||||||||||||||||||||||||||
June 30, 2022 | 202,931 | $ | 2,029 | $ | 2,315,965 | $ | (503,089) | $ | (6,584) | $ | (15,466) | $ | 1,792,855 | ||||||||||||||||||||||||||||
4
Common Stock | |||||||||||||||||||||||||||||||||||||||||
(in thousands) | Shares | Par Value | Capital in Excess of Par Value | Accum. Deficit | Accum. Other Comp. Loss | Non-controlling Interest | Total | ||||||||||||||||||||||||||||||||||
December 31, 2020 | 200,380 | $ | 2,004 | $ | 2,293,179 | $ | (638,457) | $ | (30,755) | $ | (13,396) | $ | 1,612,575 | ||||||||||||||||||||||||||||
Net income (loss) | — | — | — | 5,772 | — | (1,735) | 4,037 | ||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | 3,793 | — | 3,793 | ||||||||||||||||||||||||||||||||||
Stock-based compensation | 64 | — | 6,442 | — | — | — | 6,442 | ||||||||||||||||||||||||||||||||||
Stock options exercised | 577 | 6 | 3,341 | — | — | — | 3,347 | ||||||||||||||||||||||||||||||||||
Taxes withheld on issuance of stock-based awards | — | — | (556) | — | — | — | (556) | ||||||||||||||||||||||||||||||||||
Cumulative translation adjustments | — | — | — | — | — | 268 | 268 | ||||||||||||||||||||||||||||||||||
Distributions to noncontrolling interest | — | — | — | — | — | (800) | (800) | ||||||||||||||||||||||||||||||||||
March 31, 2021 | 201,021 | $ | 2,010 | $ | 2,302,406 | $ | (632,685) | $ | (26,962) | $ | (15,663) | $ | 1,629,106 | ||||||||||||||||||||||||||||
Net income | — | — | — | 7,250 | — | 536 | 7,786 | ||||||||||||||||||||||||||||||||||
Other comprehensive income | — | — | — | — | 14,428 | — | 14,428 | ||||||||||||||||||||||||||||||||||
Stock-based compensation | 101 | — | 5,914 | — | — | — | 5,914 | ||||||||||||||||||||||||||||||||||
Stock options exercised | 578 | 7 | 3,155 | — | — | — | 3,162 | ||||||||||||||||||||||||||||||||||
Taxes withheld on issuance of stock-based awards | — | — | (1,208) | — | — | — | (1,208) | ||||||||||||||||||||||||||||||||||
Cumulative translation adjustments | — | — | — | — | — | (231) | (231) | ||||||||||||||||||||||||||||||||||
June 30, 2021 | 201,700 | $ | 2,017 | $ | 2,310,267 | $ | (625,435) | $ | (12,534) | $ | (15,358) | $ | 1,658,957 | ||||||||||||||||||||||||||||
The accompanying notes are an integral part of the condensed consolidated financial statements.
5
CHAMPIONX CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Six Months Ended June 30, | |||||||||||
(in thousands) | 2022 | 2021 | |||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | 67,069 | $ | 11,823 | |||||||
Adjustments to reconcile net income to net cash flows from operating activities: | |||||||||||
Depreciation and amortization | 117,229 | 120,387 | |||||||||
Loss on disposal group held for sale | 22,924 | — | |||||||||
Stock-based compensation | 9,799 | 12,356 | |||||||||
Provision for inventory obsolescence and write-downs | 6,926 | 6,200 | |||||||||
Loss on debt extinguishment | 4,043 | 3,305 | |||||||||
Deferred income taxes | (34,386) | (1,757) | |||||||||
(Gain) loss on disposal of fixed assets | (6,284) | 3,176 | |||||||||
Provision (recovery) for bad debt | (732) | 86 | |||||||||
Amortization of deferred loan costs and accretion of discount | 1,766 | 1,628 | |||||||||
Employee benefit plan expense | 1,303 | 1,250 | |||||||||
Other | 234 | 167 | |||||||||
Changes in operating assets and liabilities (net of effects of foreign exchange): | |||||||||||
Receivables | (42,456) | (18,706) | |||||||||
Inventories | (81,935) | (41,586) | |||||||||
Prepaid expenses and other current assets | 16,793 | 9,215 | |||||||||
Accounts payable | 21,507 | 92,997 | |||||||||
Accrued compensation and employee benefits | (39,774) | (2,444) | |||||||||
Accrued expenses and other liabilities | (18,302) | (46,447) | |||||||||
Leased assets | (13,949) | (1,609) | |||||||||
Other | (660) | 1,097 | |||||||||
Net cash flows provided by operating activities | 31,115 | 151,138 | |||||||||
Cash flows from investing activities: | |||||||||||
Capital expenditures | (53,555) | (45,680) | |||||||||
Proceeds from sale of fixed assets | 14,946 | 2,482 | |||||||||
Acquisitions, net of cash acquired | (3,198) | — | |||||||||
Net cash used for investing activities | (41,807) | (43,198) | |||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from long-term debt | 844,838 | — | |||||||||
Repayment of long-term debt | (869,987) | (71,113) | |||||||||
Payment of debt issue costs | (8,008) | — | |||||||||
Repurchases of common stock | (20,016) | — | |||||||||
Dividends paid | (15,465) | — | |||||||||
Payments related to taxes withheld on stock-based compensation | (3,378) | (1,764) | |||||||||
Proceeds from exercise of stock options | 3,145 | 6,509 | |||||||||
Distributions to noncontrolling interest | (2,369) | (800) | |||||||||
Payment of finance lease obligations | (3,123) | (2,575) | |||||||||
Net cash used for financing activities | (74,363) | (69,743) | |||||||||
Effect of exchange rate changes on cash and cash equivalents and restricted cash | 659 | (623) | |||||||||
Net increase (decrease) in cash and cash equivalents and restricted cash | (84,396) | 37,574 | |||||||||
Cash and cash equivalents and restricted cash at beginning of period | 255,178 | 201,421 | |||||||||
Cash and cash equivalents and restricted cash at end of period | $ | 170,782 | $ | 238,995 |
The accompanying notes are an integral part of the condensed consolidated financial statements.
6
CHAMPIONX CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1—BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of the Business
ChampionX Corporation is a global leader in chemistry solutions and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently and sustainably around the world. Our products provide efficient and safe operations throughout the lifecycle of a well with a focus on the production phase of wells.
Unless the context requires otherwise, references in this report to “we,” “us,” “our,” “the Company,” or “ChampionX” mean ChampionX Corporation, together with our subsidiaries where the context requires.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of ChampionX have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) pertaining to interim financial information. As permitted under those rules, certain footnotes or other financial information that are normally required by GAAP have been condensed or omitted. Therefore, these financial statements should be read in conjunction with the audited consolidated financial statements, and notes thereto, which are included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Although these estimates are based on management’s best knowledge of current events and actions that we may undertake in the future, actual results may differ from our estimates. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments (consisting of normal recurring adjustments unless otherwise specified) necessary for a fair statement of our financial condition and results of operations as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the results and trends in these financial statements may not be representative of the results that may be expected for the year ending December 31, 2022.
Significant Accounting Policies
Please refer to “Note 1–Basis of Presentation and Summary of Significant Accounting Policies” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 for the discussion of our significant accounting policies.
New Accounting Standards
All new accounting pronouncements that have been issued but not yet effective are currently being evaluated and at this time are not expected to have a material impact on our financial position or results of operations.
NOTE 2—SEGMENT INFORMATION
Our reporting segments are:
•Production Chemical Technologies—provides oil and natural gas production and midstream markets with solutions to manage and control corrosion, oil and water separation, flow assurance, sour gas treatment and a host of water-related issues.
•Production & Automation Technologies—designs, manufactures, markets and services a full range of artificial lift equipment, end-to-end digital automation solutions, as well as other production equipment and asset monitoring technologies. Production & Automation Technologies’ products are sold under a collection of brands including Harbison-Fischer, Norris, Alberta Oil Tool, Oil Lift Technology, PCS Ferguson, Pro-Rod, Upco, Unbridled ESP, Scientific Aviation, Norriseal-Wellmark, Quartzdyne, Spirit, Theta, Timberline, Windrock, and Leak Surveys (“LSI”).
7
•Drilling Technologies—designs, manufactures and markets polycrystalline diamond cutters and bearings primarily for use in oil and gas drill bits under the US Synthetic brand.
•Reservoir Chemical Technologies—manufactures specialty products that support well stimulation, construction (including drilling and cementing) and well intervention in the oil and natural gas industry.
We refer to our Production Chemical Technologies segment and our Reservoir Chemical Technologies segment collectively as our Chemical Technologies business. Business activities that do not meet the criteria of an operating segment have been combined into Corporate and other. Corporate and other includes (i) corporate and overhead expenses, and (ii) revenue and costs for activities that are not operating segments.
Segment revenue and segment operating profit
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Segment revenue: | |||||||||||||||||||||||
Production Chemical Technologies | $ | 552,411 | $ | 447,049 | $ | 1,067,383 | $ | 859,420 | |||||||||||||||
Production & Automation Technologies | 242,399 | 188,173 | 462,748 | 355,018 | |||||||||||||||||||
Drilling Technologies | 57,858 | 37,589 | 114,717 | 72,583 | |||||||||||||||||||
Reservoir Chemical Technologies | 44,114 | 33,222 | 84,014 | 63,113 | |||||||||||||||||||
Corporate and other (1) | 35,790 | 43,139 | 69,670 | 83,926 | |||||||||||||||||||
Total revenue | $ | 932,572 | $ | 749,172 | $ | 1,798,532 | $ | 1,434,060 | |||||||||||||||
Segment operating profit (loss): | |||||||||||||||||||||||
Production Chemical Technologies | $ | 25,606 | $ | 33,871 | $ | 56,869 | $ | 64,228 | |||||||||||||||
Production & Automation Technologies | 23,650 | 12,292 | 48,360 | 17,654 | |||||||||||||||||||
Drilling Technologies | 15,043 | 3,868 | 30,263 | 10,254 | |||||||||||||||||||
Reservoir Chemical Technologies | (8,147) | (2,594) | (11,616) | (5,822) | |||||||||||||||||||
Total segment operating profit | 56,152 | 47,437 | 123,876 | 86,314 | |||||||||||||||||||
Corporate and other (1) | 17,896 | 22,024 | 29,690 | 40,111 | |||||||||||||||||||
Interest expense, net | 10,765 | 14,064 | 22,128 | 28,035 | |||||||||||||||||||
Income before income taxes | $ | 27,491 | $ | 11,349 | $ | 72,058 | $ | 18,168 |
_______________________
(1) Corporate and other includes costs not directly attributable or allocated to our reporting segments such as corporate executive management and other administrative functions, and the results attributable to our noncontrolling interest. Additionally, the sales and expenses related to the Cross Supply and Product Transfer Agreement with Ecolab Inc. (“Ecolab”) are included within Corporate and other.
NOTE 3—REVENUE
Our revenue is generated primarily from product sales. Service revenue is generated from providing services to our customers. These services include installation, repair and maintenance, laboratory and logistics services, chemical management services, troubleshooting, reporting, water treatment services, technical advisory assistance, emissions detection and monitoring, and other field services. Lease revenue is derived from rental income of leased production equipment. As our costs are shared across the various revenue categories, cost of goods sold is not tracked separately and is not discretely identifiable.
In certain geographical areas, the Company utilizes joint ventures and independent third-party distributors and sales agents to sell and market products and services. Amounts payable to independent third-party distributors and sales agents may fluctuate based on sales and timing of distributor fee payments. For services rendered by such independent third-party distributors and sales agents, the Company records the consideration received on a net basis within product revenue in our condensed consolidated statements of income. Additionally, amounts owed to distributors and sales agents are reported within accrued distributor fees within our condensed consolidated balance sheets.
8
Revenue disaggregated by geography was as follows:
Three Months Ended June 30, 2022 | |||||||||||||||||||||||||||||||||||
(in thousands) | Production Chemical Technologies | Production & Automation Technologies | Drilling Technologies | Reservoir Chemical Technologies | Corporate and other (1) | Total | |||||||||||||||||||||||||||||
United States | $ | 205,457 | $ | 187,982 | $ | 45,848 | $ | 31,038 | $ | 20,039 | $ | 490,364 | |||||||||||||||||||||||
Latin America | 124,540 | 6,358 | — | 3,221 | 905 | 135,024 | |||||||||||||||||||||||||||||
Middle East & Africa | 76,028 | 19,062 | 1,220 | 5,561 | 287 | 102,158 | |||||||||||||||||||||||||||||
Canada | 72,581 | 17,484 | 3,477 | 633 | 37 | 94,212 | |||||||||||||||||||||||||||||
Europe | 45,889 | 3,384 | 5,156 | 968 | 3,297 | 58,694 | |||||||||||||||||||||||||||||
Asia-Pacific | 9,518 | 784 | 2,142 | 909 | 11,225 | 24,578 | |||||||||||||||||||||||||||||
Australia | 4,960 | 7,308 | 15 | 91 | — | 12,374 | |||||||||||||||||||||||||||||
Other | 13,438 | 37 | — | 1,693 | — | 15,168 | |||||||||||||||||||||||||||||
Total revenue | $ | 552,411 | $ | 242,399 | $ | 57,858 | $ | 44,114 | $ | 35,790 | $ | 932,572 | |||||||||||||||||||||||
Three Months Ended June 30, 2021 | |||||||||||||||||||||||||||||||||||
(in thousands) | Production Chemical Technologies | Production & Automation Technologies | Drilling Technologies | Reservoir Chemical Technologies | Corporate and other (1) | Total | |||||||||||||||||||||||||||||
United States | $ | 156,852 | $ | 141,799 | $ | 30,392 | $ | 19,589 | $ | 30,225 | $ | 378,857 | |||||||||||||||||||||||
Latin America | 93,389 | 4,530 | — | 3,587 | 1,261 | 102,767 | |||||||||||||||||||||||||||||
Middle East & Africa | 66,213 | 13,358 | 1,446 | 6,534 | 1,945 | 89,496 | |||||||||||||||||||||||||||||
Canada | 63,639 | 14,754 | 1,986 | 377 | 124 | 80,880 | |||||||||||||||||||||||||||||
Europe | 41,046 | 1,790 | 2,278 | 1,101 | 3,690 | 49,905 | |||||||||||||||||||||||||||||
Asia-Pacific | 10,562 | 2,743 | 853 | 1,393 | 5,894 | 21,445 | |||||||||||||||||||||||||||||
Australia | 5,994 | 9,182 | 13 | 30 | — | 15,219 | |||||||||||||||||||||||||||||
Other | 9,354 | 17 | 621 | 611 | — | 10,603 | |||||||||||||||||||||||||||||
Total revenue | $ | 447,049 | $ | 188,173 | $ | 37,589 | $ | 33,222 | $ | 43,139 | $ | 749,172 |
9
Six Months Ended June 30, 2022 | |||||||||||||||||||||||||||||||||||
(in thousands) | Production Chemical Technologies | Production & Automation Technologies | Drilling Technologies | Reservoir Chemical Technologies | Corporate and other (1) | Total | |||||||||||||||||||||||||||||
United States | $ | 396,363 | $ | 355,784 | $ | 92,667 | $ | 56,259 | $ | 41,893 | $ | 942,966 | |||||||||||||||||||||||
Latin America | 224,145 | 11,361 | — | 6,811 | 1,630 | 243,947 | |||||||||||||||||||||||||||||
Middle East & Africa | 150,072 | 35,773 | 2,909 | 13,282 | 601 | 202,637 | |||||||||||||||||||||||||||||
Canada | 148,380 | 36,936 | 6,418 | 1,111 | 63 | 192,908 | |||||||||||||||||||||||||||||
Europe | 94,910 | 5,729 | 8,866 | 1,871 | 6,768 | 118,144 | |||||||||||||||||||||||||||||
Asia-Pacific | 18,001 | 2,455 | 3,817 | 1,954 | 18,715 | 44,942 | |||||||||||||||||||||||||||||
Australia | 10,803 | 14,583 | 15 | 199 | — | 25,600 | |||||||||||||||||||||||||||||
Other | 24,709 | 127 | 25 | 2,527 | — | 27,388 | |||||||||||||||||||||||||||||
Total revenue | $ | 1,067,383 | $ | 462,748 | $ | 114,717 | $ | 84,014 | $ | 69,670 | $ | 1,798,532 | |||||||||||||||||||||||
Six Months Ended June 30, 2021 | |||||||||||||||||||||||||||||||||||
(in thousands) | Production Chemical Technologies | Production & Automation Technologies | Drilling Technologies | Reservoir Chemical Technologies | Corporate and other (1) | Total | |||||||||||||||||||||||||||||
United States | $ | 306,716 | $ | 267,712 | $ | 55,799 | $ | 35,198 | $ | 56,242 | $ | 721,667 | |||||||||||||||||||||||
Latin America | 165,005 | 9,172 | — | 6,606 | 2,692 | 183,475 | |||||||||||||||||||||||||||||
Middle East & Africa | 124,583 | 24,091 | 2,162 | 12,596 | 7,067 | 170,499 | |||||||||||||||||||||||||||||
Canada | 124,931 | 27,282 | 5,813 | 1,106 | 282 | 159,414 | |||||||||||||||||||||||||||||
Europe | 83,654 | 3,773 | 4,777 | 2,490 | 5,947 | 100,641 | |||||||||||||||||||||||||||||
Asia-Pacific | 21,054 | 4,206 | 2,406 | 2,513 | 11,696 | 41,875 | |||||||||||||||||||||||||||||
Australia | 12,389 | 18,758 | 130 | 84 | — | 31,361 | |||||||||||||||||||||||||||||
Other | 21,088 | 24 | 1,496 | 2,520 | — | 25,128 | |||||||||||||||||||||||||||||
Total revenue | $ | 859,420 | $ | 355,018 | $ | 72,583 | $ | 63,113 | $ | 83,926 | $ | 1,434,060 |
______________________
(1) Revenues associated with sales under the Cross Supply and Product Transfer Agreement with Ecolab are included within Corporate and other.
Revenue is attributed to regions based on the location of our direct customer, which in some instances is an intermediary and not necessarily the end user.
Contract Balances
The beginning and ending contract asset and contract liability balances from contracts with customers were as follows:
(in thousands) | June 30, 2022 | December 31, 2021 | |||||||||
Contract assets | $ | — | $ | — | |||||||
Contract liabilities - current | $ | 16,700 | $ | 15,246 |
10
NOTE 4—INTANGIBLE ASSETS AND GOODWILL
Intangible Assets
The components of our definite- and indefinite-lived intangible assets were as follows:
June 30, 2022 | December 31, 2021 | ||||||||||||||||||||||||||||||||||
(in thousands) | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | Gross Carrying Amount | Accumulated Amortization | Net Carrying Amount | |||||||||||||||||||||||||||||
Definite-lived intangible assets: | |||||||||||||||||||||||||||||||||||
Customer relationships | $ | 585,450 | $ | 386,613 | $ | 198,837 | $ | 593,242 | $ | 365,773 | $ | 227,469 | |||||||||||||||||||||||
Unpatented technologies | 142,760 | 46,815 | 95,945 | 142,540 | 37,264 | 105,276 | |||||||||||||||||||||||||||||
Favorable supply agreements | 59,000 | 40,164 | 18,836 | 59,000 | 30,546 | 28,454 | |||||||||||||||||||||||||||||
Trademarks | 59,869 | 34,163 | 25,706 | 59,873 | 32,270 | 27,603 | |||||||||||||||||||||||||||||
Patents | 38,577 | 31,417 | 7,160 | 38,735 | 31,080 | 7,655 | |||||||||||||||||||||||||||||
Other | 5,357 | 5,267 | 90 | 5,390 | 5,177 | 213 | |||||||||||||||||||||||||||||
891,013 | 544,439 | 346,574 | 898,780 | 502,110 | 396,670 | ||||||||||||||||||||||||||||||
Indefinite-lived intangible assets: | |||||||||||||||||||||||||||||||||||
Trademarks | 3,600 | — | 3,600 | 3,600 | — | 3,600 | |||||||||||||||||||||||||||||
In-process research and development | 1,200 | — | 1,200 | 1,200 | — | 1,200 | |||||||||||||||||||||||||||||
4,800 | — | 4,800 | 4,800 | — | 4,800 | ||||||||||||||||||||||||||||||
Total | $ | 895,813 | $ | 544,439 | $ | 351,374 | $ | 903,580 | $ | 502,110 | $ | 401,470 |
Goodwill
The carrying amount of goodwill, including changes therein, by reportable segment is below:
(in thousands) | Production Chemical Technologies | Production & Automation Technologies | Drilling Technologies | Reservoir Chemical Technologies | Total | ||||||||||||||||||||||||
December 31, 2021 | $ | 356,638 | $ | 205,467 | $ | 101,136 | $ | 39,626 | $ | 702,867 | |||||||||||||||||||
Acquisition (1) | — | 6,345 | — | — | 6,345 | ||||||||||||||||||||||||
Allocated to disposal group (2) | (3,339) | — | — | — | (3,339) | ||||||||||||||||||||||||
Foreign currency translation | 17,146 | (156) | — | 1,535 | 18,525 | ||||||||||||||||||||||||
June 30, 2022 | $ | 370,445 | $ | 211,656 | $ | 101,136 | $ | 41,161 | $ | 724,398 |
_______________________
(1) See Note 11—Acquisitions and Divestitures for additional information related to the acquisition of LSI completed during the first quarter of 2022.
(2) See Note 11—Acquisitions and Divestitures for additional information on the reclassification of assets and liabilities held for sale as part of the planned divestiture of our operations in Russia.
Goodwill is not subject to amortization but is tested for impairment on an annual basis or more frequently if impairment indicators arise.
11
NOTE 5—DEBT
Long-term debt consisted of the following:
(in thousands) | June 30, 2022 | December 31, 2021 | |||||||||
2022 Revolving Credit Facility | $ | 96,200 | $ | — | |||||||
2018 Term Loan Facility | — | 140,000 | |||||||||
2020 Term Loan Facility | — | 496,725 | |||||||||
2022 Term Loan Facility | 625,000 | — | |||||||||
6.375% Senior Notes due 2026 | — | 92,041 | |||||||||
Total | 721,200 | 728,766 | |||||||||
Net unamortized discounts and issuance costs | (22,082) | (4,259) | |||||||||
Total long-term debt | 699,118 | 724,507 | |||||||||
Current portion of long-term debt (1) | (4,688) | (26,850) | |||||||||
Long-term debt, less current portion | $ | 694,430 | $ | 697,657 |
_______________________
(1) Represents the mandatory amortization payments due within twelve months related to the 2022 Term Loan Facility as of June 30, 2022 and 2020 Term Loan Facility as of December 31, 2021.
On May 9, 2018, we entered into a credit agreement (“Credit Agreement”) governing the terms of, among other things, a 7-year senior secured term loan B facility that had an initial commitment of $415 million (the “2018 Term Loan Facility”), and on June 3, 2020, ChampionX Holdings Inc. entered into a term loan facility for $537.0 million (the “2020 Term Loan Facility”).
On June 7, 2022, we entered into a restated credit agreement (the “Restated Credit Agreement”), which amends and restates the Credit Agreement. The Restated Credit Agreement provides for (i) a $625 million 7-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700 million, of which $100 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility,” together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022, with the aggregate proceeds used to repay outstanding amounts under our Credit Agreement, repay and terminate our 2020 Term Loan Facility, and to redeem all outstanding 6.375% Senior Notes due 2026. Proceeds from future borrowings under the 2022 Revolving Credit Facility are expected to be used for working capital and general corporate purposes. Following June 7, 2022, and prior to June 30, 2022, we repaid $38.8 million of the amount drawn under the 2022 Revolving Credit Facility.
The 2022 Term Loan Facility matures June 7, 2029 and the 2022 Revolving Credit Facility matures June 7, 2027. The 2022 Term Loan Facility is subject to mandatory amortization payments of 1% per annum of the initial commitment paid quarterly, which begins on December 30, 2022. The Senior Secured Credit Facility contains customary representations and warranties, covenants, and events of default for loan facilities of this type. We were in compliance with all covenants as of June 30, 2022.
At the Company’s election, outstanding borrowings under the Senior Secured Credit Facility will accrue interest at a per annum rate of (i) an adjusted SOFR rate plus the applicable spread or (ii) a base rate plus the applicable spread. On June 29, 2022, the Company executed a five-year floating-to-fixed interest rate swap to hedge our exposure to increases in variable interest rates on the 2022 Term Loan Facility. This interest rate swap agreement is based on a $300 million notional amount for the first three years, reducing to $150 million for years four and five. See Note 13—Derivatives and Hedging Transactions for additional information on interest rate swaps.
In connection with the Restated Credit Agreement noted above, we completed the redemption of all of the Company’s remaining 6.375% Senior Notes (the “Notes”) at 103.188% of the principal amount thereof. We repurchased $92.0 million in aggregate principal amount of the Notes for $95.6 million in cash, including $0.6 million in accrued interest. In connection with these redemptions, we recognized a net loss of approximately $3.9 million for the three and six months ended June 30, 2022, inclusive of the write off of the remaining unamortized debt financing costs related to the Notes, which is included in other expense, net in our condensed consolidated statements of income (loss).
12
NOTE 6—COMMITMENTS AND CONTINGENCIES
Guarantees and Indemnifications
We have provided indemnities in connection with sales of certain businesses and assets, including indemnities for environmental health and safety, tax, and employment matters. We do not have any material liabilities recorded for these indemnifications and are not aware of any claims or other information that would give rise to material payments under such indemnities.
In connection with the Company’s separation from Dover Corporation (“Dover”) in 2018, we entered into agreements with Dover that govern the treatment between Dover and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Dover’s business with Dover. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters.
In connection with the acquisition of the Chemical Technologies business from Ecolab in 2020 (the “Merger”), we entered into agreements with Ecolab that govern the treatment between Ecolab and us for certain indemnification matters and litigation responsibility. Generally, the separation and distribution agreement provides for cross-indemnities principally designed to place financial responsibility for the obligations and liabilities of our business with us and to place financial responsibility for the obligations and liabilities of Ecolab’s business with Ecolab. The separation and distribution agreement also establishes procedures for handling claims subject to indemnification and related matters. In addition, pursuant to the tax matters agreement relating to the Merger (the “Tax Matters Agreement”), we have agreed to indemnify Ecolab and its affiliates for (i) all taxes for which ChampionX is responsible as defined within the Tax Matters Agreement, (ii) all taxes resulting from a breach by ChampionX of any of its representations (but only to the extent relating to a breach occurring after the consummation of the Merger) or any of its covenants under the Tax Matters Agreement, (iii) all taxes resulting from an acquisition after the Merger of any of the stock or assets of ChampionX, other than as a result of the Merger or a repayment of the 2018 Credit Facility (as defined in “Note 8–Debt” to our consolidated financial statements in our Annual Report on Form 10-K for the fiscal
year ended December 31, 2021), 2018 Term Loan Facility or 2020 Term Loan Facility and (iv) reasonable costs and expenses (including reasonable attorneys’ fees and expenses) related to the foregoing.
As of June 30, 2022 and December 31, 2021, we had $56.2 million and $80.2 million, respectively, of outstanding letters of credit, surety bonds and guarantees, which expire at various dates through 2039. These financial instruments are primarily maintained as security for insurance, warranty, and other performance obligations. Generally, we would only be liable for the amount of these letters of credit, surety bonds, and guarantees in the event of default in the performance of our obligations, the probability of which we believe is remote.
Litigation and Environmental Matters
The Company is party to various proceedings and claims incidental to its business, including matters arising under provisions relating to the protection of the environment. We review the probable outcome of such proceedings, the costs and expenses reasonably expected to be incurred and accrued to date, and the availability and extent of insurance coverage. We accrue a liability for legal matters that are probable and can be reasonably estimated. If the reasonable estimate of a probable loss is a range, the Company records the most probable estimate of the loss or the minimum amount when no amount within the range is a better estimate than any other amount. While many of these matters involve inherent uncertainty, we believe that the amount of the liability, if any, ultimately incurred with respect to these proceedings and claims will not have a material adverse effect on our consolidated financial position, results of operations or cash flows.
Environmental Matters
The Company is currently participating in environmental assessments and remediation at approximately 11 locations, the majority of which are in the United States (“U.S.”), and environmental liabilities have been accrued reflecting our best estimate of future costs. Potential insurance reimbursements are not anticipated in the Company’s accruals for environmental liabilities. As of June 30, 2022, environmental liability accruals related to these locations were $6.9 million.
Prior to the separation from Dover in 2018, groundwater contamination was discovered at the Norris Sucker Rods plant site located in Tulsa, Oklahoma (“Norris”). Initial remedial efforts were undertaken at the time of discovery of the contamination and Norris has since coordinated monitoring and remediation with the Oklahoma Department of Environmental Quality (“ODEQ”). As part of the ongoing long-term remediation process, Norris contracted an engineering and consulting firm to develop a range of possible additional remedial alternatives in order to accelerate the remediation process and associated cost
13
estimates for the work. In October 2019, we received the firm’s preliminary remedial alternatives for consideration. We have submitted our long-term remediation plan and it was approved by ODEQ. We are now in discussion with ODEQ to finalize a consent order. Because we have not yet finalized the consent order for further remediation at the site and discussions with ODEQ remain ongoing, we cannot fully anticipate the timing, outcome or possible impact of such further remedial activities, financial or otherwise. As a result of the recommendations in the report, we accrued liabilities for these remediation efforts of approximately $2.0 million as of December 31, 2019. Liabilities could increase in the future at such time as we ultimately reach agreement with ODEQ on our remediation plan and such liabilities become probable and can be reasonably estimated; however, there have been no changes to our estimated liability as of June 30, 2022.
Matters Related to Deepwater Horizon Incident Response
On April 22, 2010, the deepwater drilling platform, the Deepwater Horizon, operated by a subsidiary of BP plc, sank in the Gulf of Mexico after an explosion and fire, resulting in a massive oil spill. Certain entities that are now subsidiaries of ChampionX as a result of the Merger (collectively the “COREXIT Defendants”) supplied COREXIT™ 9500, an oil dispersant product listed on the U.S. EPA National Contingency Plan Product Schedule, which was used in the response to the spill. In connection with the provision of COREXIT™, the COREXIT Defendants were named in several lawsuits. Cases arising out of the Deepwater Horizon accident were administratively transferred and consolidated for pre-trial purposes under In Re: Oil Spill by the Oil Rig “Deepwater Horizon” in the Gulf of Mexico, on April 20, 2010, Case No. 10-md-02179 in the United States District Court in the Eastern District of Louisiana (E.D. La.) (“MDL 2179”). Claims related to the response to the oil spill were consolidated in a master complaint captioned the “B3 Master Complaint.” In 2011, Transocean Deepwater Drilling, Inc. and its affiliates (the “Transocean Entities”) named the COREXIT Defendants and other unaffiliated companies as first party defendants (In re the Complaint and Petition of Triton Asset Leasing GmbH, et al, MDL No. 2179, Civil Action 10-2771). In April and May 2011, the Transocean Entities, Cameron International Corporation, Halliburton Energy Services, Inc., M-I L.L.C., Weatherford U.S., L.P. and Weatherford International, Inc. (collectively, the “Cross Claimants”) filed cross claims in MDL 2179 against the COREXIT Defendants and other unaffiliated cross defendants. In April and June 2011, in support of its defense of the claims against it, the COREXIT Defendants filed counterclaims against the Cross Claimants. On May 18, 2012, the COREXIT Defendants filed a motion for summary judgment as to the claims in the B3 Master Complaint. On November 28, 2012, the Court granted the COREXIT Defendants’ motion and dismissed with prejudice the claims in the B3 Master Complaint asserted against the COREXIT Defendants. There currently remain three “B3” cases that had asserted claims against the COREXIT Defendants and that remain pending against other defendants. Because the Court’s decision was not a “final judgment” for purposes of appeal with respect to those claims, under Federal Rule of Appellate Procedure 4(a), plaintiffs will have 30 days after entry of final judgment in each case to appeal the Court’s summary judgment decision.
The Company believes the claims asserted against the COREXIT Defendants are without merit and intends to defend these lawsuits vigorously. The Company also believes that it has rights to contribution and/or indemnification (including legal expenses) from third parties. However, we cannot predict the outcome of these lawsuits, the involvement it might have in these matters in the future, or the potential for future litigation.
14
NOTE 7—RESTRUCTURING AND OTHER RELATED CHARGES
We approved various restructuring plans related to the consolidation of product lines and associated facility closures and workforce reductions during the current and prior periods. During the second quarter of 2022, the restructuring plans included the exit of one of our product lines within the Reservoir Chemical Technologies segment. The exit of this product line is expected to be completed during the third quarter of 2022 and as such, we anticipate additional restructuring charges related to the closure of facilities and certain contract termination costs when we cease using the rights conveyed by the contract.
We recognized charges of $6.6 million and $15.1 million during the three and six months ended June 30, 2022, respectively, consisting primarily of employee severance and related benefits, disposals of equipment and office closures, partially offset by gains realized on the sale of facilities. During the three and six months ended June 30, 2021, we recorded restructuring and other charges of $3.8 million and $8.0 million, respectively.
The following table presents the restructuring and other related charges by segment as classified in our condensed consolidated statements of income.
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Segment restructuring charges (income): | |||||||||||||||||||||||
Production Chemical Technologies | $ | 336 | $ | 3,103 | $ | 11,972 | $ | 3,791 | |||||||||||||||
Production & Automation Technologies | 125 | 432 | (4,022) | 3,956 | |||||||||||||||||||
Drilling Technologies | — | — | — | — | |||||||||||||||||||
Reservoir Chemical Technologies | 5,358 | 198 | 6,101 | 242 | |||||||||||||||||||
Corporate and other | 801 | 42 | 1,053 | 42 | |||||||||||||||||||
Total | $ | 6,620 | $ | 3,775 | $ | 15,104 | $ | 8,031 | |||||||||||||||
Statements of Income classification: | |||||||||||||||||||||||
Cost of goods and services | $ | 5,147 | $ | 422 | $ | 1,008 | $ | 3,906 | |||||||||||||||
Selling, general and administrative expense | 1,473 | 3,353 | 14,096 | 4,125 | |||||||||||||||||||
Total | $ | 6,620 | $ | 3,775 | $ | 15,104 | $ | 8,031 |
Our liability balance for restructuring and other related charges at June 30, 2022 reflects employee severance and related benefits initiated during the period. Additional programs may be initiated during 2022 with related restructuring charges.
The following table details our restructuring accrual activities during the six months ended June 30, 2022:
(in thousands) | Restructuring Accrual Balance | ||||
December 31, 2021 | $ | 3,743 | |||
Restructuring charges | 15,104 | ||||
Asset sales | 131 | ||||
Payments | (10,590) | ||||
Other, including foreign currency translation | (99) | ||||
June 30, 2022 | $ | 8,289 |
15
NOTE 8—EQUITY AND CASH INCENTIVE PROGRAMS
Stock-based compensation expense is reported within selling, general and administrative expense in the condensed consolidated statements of income. Stock-based compensation expense relating to all stock-based incentive plans was as follows:
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Stock-based compensation expense | $ | 5,071 | $ | 5,914 | $ | 9,799 | $ | 12,356 | |||||||||||||||
Tax benefit | (1,065) | (1,242) | (2,058) | (2,595) | |||||||||||||||||||
Stock-based compensation expense, net of tax | $ | 4,006 | $ | 4,672 | $ | 7,741 | $ | 9,761 |
A summary of activity relating to our share-based awards for the six months ended June 30, 2022 was as follows:
(in shares) | Stock-Settled Appreciation Rights | Performance Share Awards | Restricted Stock Units | Non-Qualified Stock Options | |||||||||||||||||||
Outstanding at January 1, 2022 | 393,523 | 505,509 | 2,342,107 | 5,488,653 | |||||||||||||||||||
Granted | — | 347,920 | 932,588 | — | |||||||||||||||||||
Forfeited / expired | (1,758) | — | (159,365) | (2,859) | |||||||||||||||||||
Exercised / vested | — | (72,410) | (437,275) | (499,562) | |||||||||||||||||||
Outstanding at June 30, 2022 | 391,765 | 781,019 | 2,678,055 | 4,986,232 |
16
NOTE 9—STOCKHOLDERS' EQUITY
Dividends
On February 4, 2022, our Board of Directors (“Board”) approved a plan to initiate a regular quarterly cash dividend of $0.075 per share of the Company’s common stock. The first dividend was paid on April 29, 2022 to stockholders of record on April 8, 2022. An additional cash dividend of $0.075 per share was declared on May 12, 2022, payable on July 29, 2022 to stockholders of record on July 1, 2022. As a result, we recorded a dividend payable of $15.3 million on our condensed consolidated balance sheet as of June 30, 2022. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors.
Repurchases
On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock. During the three and six months ended June 30, 2022, we repurchased and cancelled 789,516 shares of common stock at an average price of $25.33 per share for a total of $20.0 million.
Accumulated other comprehensive loss
Accumulated other comprehensive loss—Accumulated other comprehensive loss consisted of the following:
(in thousands) | Foreign Currency Translation | Defined Pension and Other Post-Retirement Benefits | Cash Flow Hedges | Accumulated Other Comprehensive Loss | |||||||||||||||||||
December 31, 2021 | $ | (19,430) | $ | (3,476) | $ | 1,281 | $ | (21,625) | |||||||||||||||
Other comprehensive loss before reclassifications, net of tax | (1,565) | — | (1,299) | (2,864) | |||||||||||||||||||
Reclassification adjustment for net losses included in net income, net of tax | — | 69 | — | 69 | |||||||||||||||||||
Other comprehensive loss, net of tax | (1,565) | 69 | (1,299) | (2,795) | |||||||||||||||||||
March 31, 2022 | $ | (20,995) | $ | (3,407) | $ | (18) | $ | (24,420) | |||||||||||||||
Other comprehensive income before reclassifications, net of tax | 21,169 | — | (3,403) | 17,766 | |||||||||||||||||||
Reclassification adjustment for net losses included in net income, net of tax | — | 70 | — | 70 | |||||||||||||||||||
Other comprehensive income, net of tax | 21,169 | 70 | (3,403) | 17,836 | |||||||||||||||||||
June 30, 2022 | $ | 174 | $ | (3,337) | $ | (3,421) | $ | (6,584) | |||||||||||||||
17
(in thousands) | Foreign Currency Translation | Defined Pension and Other Post-Retirement Benefits | Cash Flow Hedges | Accumulated Other Comprehensive Loss | |||||||||||||||||||
December 31, 2020 | $ | (14,965) | $ | (13,470) | $ | (2,320) | $ | (30,755) | |||||||||||||||
Other comprehensive income before reclassifications, net of tax | 3,213 | — | 413 | 3,626 | |||||||||||||||||||
Reclassification adjustment for net losses included in net income, net of tax | — | 167 | — | 167 | |||||||||||||||||||
Other comprehensive income, net of tax | 3,213 | 167 | 413 | 3,793 | |||||||||||||||||||
March 31, 2021 | $ | (11,752) | $ | (13,303) | $ | (1,907) | $ | (26,962) | |||||||||||||||
Other comprehensive income (loss) before reclassifications, net of tax | 8,332 | — | (277) | 8,055 | |||||||||||||||||||
Reclassification adjustment for net losses included in net income, net of tax | — | 6,373 | — | 6,373 | |||||||||||||||||||
Other comprehensive income (loss), net of tax | 8,332 | 6,373 | (277) | 14,428 | |||||||||||||||||||
June 30, 2021 | $ | (3,420) | $ | (6,930) | $ | (2,184) | $ | (12,534) | |||||||||||||||
Reclassifications from accumulated other comprehensive loss—Reclassification adjustments from accumulated other comprehensive loss to net income (loss) related to defined pension and other post-retirement benefits consisted of the following:
Three Months Ended June 30, | Six Months Ended June 30, | Affected line items on the condensed consolidated statements of income (loss) | |||||||||||||||||||||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||||||||
Pensions and other post-retirement benefits: | |||||||||||||||||||||||||||||
Amortization of actuarial loss and other | $ | 70 | $ | 6,326 | $ | 139 | $ | 6,540 | Other (income) expense, net | ||||||||||||||||||||
Total before tax | 70 | 6,326 | 139 | 6,540 | Income before income taxes | ||||||||||||||||||||||||
Tax benefit | — | 47 | — | — | Provision for (benefit from) income taxes | ||||||||||||||||||||||||
Net of tax | $ | 70 | $ | 6,373 | $ | 139 | $ | 6,540 | Net income |
NOTE 10—EARNINGS PER SHARE
A reconciliation of the number of shares used for the basic and diluted earnings per share calculation was as follows:
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(in thousands, except per share data) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Net income attributable to ChampionX | $ | 27,342 | $ | 7,250 | $ | 64,044 | $ | 13,022 | |||||||||||||||
Weighted-average number of shares outstanding | 203,322 | 201,467 | 203,200 | 201,063 | |||||||||||||||||||
Dilutive effect of stock-based compensation | 5,392 | 7,074 | 5,663 | 6,876 | |||||||||||||||||||
Total shares and dilutive securities | 208,714 | 208,541 | 208,863 | 207,939 | |||||||||||||||||||
Basic earnings per share attributable to ChampionX | $ | 0.13 | $ | 0.04 | $ | 0.32 | $ | 0.06 | |||||||||||||||
Diluted earnings per share attributable to ChampionX | $ | 0.13 | $ | 0.03 | $ | 0.31 | $ | 0.06 |
For all periods presented, the computation of diluted earnings per share excludes awards with an anti-dilutive impact. For the three and six months ended June 30, 2022, the diluted shares include the dilutive impact of equity awards except for approximately 0.4 million and 0.4 million shares, respectively, that were excluded because their inclusion would be anti-dilutive. For the three and six months ended June 30, 2021, the diluted shares include the dilutive impact of equity awards
18
except for approximately 0.7 million and 0.7 million shares, respectively, that were excluded because their inclusion would be anti-dilutive.
NOTE 11—ACQUISITIONS AND DIVESTITURES
Acquisitions
On February 23, 2022, we acquired LSI, a leader in optical gas imaging technology that provides aerial and ground-based emissions leak detection to the oil and gas industry. LSI has been included in our Production & Automation Technologies segment. Under the terms of the agreement, we paid an initial amount of $3.2 million, net of cash acquired, with an additional $0.5 million payable on the first anniversary of the closing date. We may also be required to make future payments of up to an additional $2.5 million, contingent on the future performance of the business. As part of our purchase price allocation, we recorded goodwill of $6.3 million. The pro forma effect of this acquisition on revenue and net income has been determined to be immaterial to our financial statements.
Divestitures
Given the continued economic pressure and sanctions imposed by the United States, European Union, and United Kingdom, we have initiated a plan to dispose of our operations in Russia (the “CT Russia Business”), which is included in our Production Chemical Technologies segment. As a result, the CT Russia Business met the criteria to be classified as held for sale as of June 30, 2022, which requires us to present the related assets and liabilities as separate line items in our condensed consolidated balance sheet. We recorded a charge of $22.9 million for the three and six months ended June 30, 2022, in order to properly reflect the carrying value of the disposal group at the lower of its carrying value or fair value less any costs to sell. We assess the fair value of a long-lived asset or disposal group (less any costs to sell) each reporting period that it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset or disposal group, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale. Upon the ultimate disposition, we will recognize the cumulative translation adjustment balance associated with the CT Russia Business in our condensed consolidated statement of income as part of the gain or loss on the sale.
The following table presents information related to the major classes of assets and liabilities that were held for sale in our condensed consolidated balance sheet:
(in thousands) | |||||
Receivables | $ | 9,708 | |||
Inventory | 10,830 | ||||
Prepaid expenses and other current assets | 3,670 | ||||
Property, plant, and equipment | 5,455 | ||||
Goodwill | 3,339 | ||||
Intangible assets | 7,803 | ||||
Operating lease right-of-use assets | 2,419 | ||||
Loss on disposal group | (22,924) | ||||
Total assets held for sale | $ | 20,300 | |||
Accounts payable | $ | 2,840 | |||
Other current liabilities | 3,719 | ||||
Other noncurrent liabilities | 3,869 | ||||
Total liabilities held for sale | $ | 10,428 |
19
NOTE 12—FAIR VALUE MEASUREMENTS
Fair value is defined as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants as of the measurement date. A hierarchy has been established for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs be used when available. The hierarchy is broken down into three levels:
Level 1- Inputs are quoted prices in active markets that are accessible at the measurement date for identical assets or liabilities.
Level 2- Inputs include observable inputs other than quoted prices in active markets.
Level 3- Inputs are unobservable inputs for which there is little or no market data available.
The carrying amount and the estimated fair value for assets and liabilities measured on a recurring basis are as follows:
Carrying Amount | |||||||||||||||||
(in thousands) | Measurement Level | June 30, 2022 | December 31, 2021 | ||||||||||||||
Assets | |||||||||||||||||
Foreign currency forward contracts | Level 2 | $ | 3,423 | $ | 4,081 | ||||||||||||
Interest rate swaps | Level 2 | 392 | — | ||||||||||||||
Total | $ | 3,815 | $ | 4,081 | |||||||||||||
Liabilities | |||||||||||||||||
Foreign currency forward contracts | Level 2 | $ | 3,445 | $ | 3,773 | ||||||||||||
Interest rate swaps | Level 2 | 4,390 | — | ||||||||||||||
Total | $ | 7,835 | $ | 3,773 |
For purposes of fair value disclosure above, derivative values are presented gross. See Note 13—Derivatives and Hedging Transactions for further discussion of gross versus net presentation of the Company’s derivatives.
The carrying amounts of cash and cash equivalents, trade receivables, accounts payable, as well as amounts included in other current assets and other current liabilities that meet the definition of financial instruments, approximate fair value due to their short-term nature.
The carrying amount and the estimated fair value of long-term debt, including current maturities, held by the Company were:
June 30, 2022 | December 31, 2021 | ||||||||||||||||||||||
(in thousands) | Carrying Amount | Fair Value | Carrying Amount | Fair Value | |||||||||||||||||||
2022 Revolving Credit Facility | $ | 96,200 | $ | 96,200 | $ | — | $ | — | |||||||||||||||
2018 Term Loan Facility | $ | — | $ | — | $ | 140,000 | $ | 138,950 | |||||||||||||||
2020 Term Loan Facility | $ | — | $ | — | $ | 496,725 | $ | 502,313 | |||||||||||||||
2022 Term Loan Facility | $ | 625,000 | $ | 607,031 | $ | — | $ | — | |||||||||||||||
6.375% Senior Notes due 2026 | $ | — | $ | — | $ | 92,041 | $ | 95,805 |
The fair value of our 6.375% Senior Notes due 2026 is based on Level 1 quoted market prices. The fair value of our term loan facilities are based on Level 2 quoted market prices for the same or similar debt instruments. The fair value of our revolving line of credit approximates carrying value due to the variable interest rates charged on the borrowings, which reprice frequently (Level 2).
NOTE 13—DERIVATIVES AND HEDGING TRANSACTIONS
The Company uses foreign currency forward contracts to manage risks associated with foreign currency exchange rates. The Company also utilizes floating-to-fixed interest rate swap agreements as cash flow hedges on certain debt, to mitigate interest rate risk. The Company does not hold derivative financial instruments of a speculative nature or for trading purposes. Derivative contracts are recorded as assets and liabilities on the balance sheet at fair value. We evaluated the interest rate swap hedge effectiveness and determined it to be perfectly effective. We evaluate foreign currency forward contracts hedge
20
effectiveness at contract inception and thereafter on a quarterly basis. If a derivative is no longer expected to be effective, hedge accounting is discontinued. Changes in fair value are recognized immediately in earnings unless the derivative qualifies and is designated as a hedge. Changes in fair value attributable to changes in spot exchange rates for derivative contracts that have been designated as cash flow hedges are recognized in accumulated other comprehensive income (loss) (“AOCI”) and reclassified into earnings in the same period the hedged transaction affects earnings and are presented in the same income statement line as the earnings effect of the hedged item. The Company accounts for the interest rate swap agreements as a cash flow hedge, thus the effective portion of gains and losses resulting from changes in fair value are recognized in AOCI and are amortized to interest expense over the term of the respective debt. Cash flows from derivatives are classified in the statement of cash flows in the same category as the cash flows from the items subject to designated hedge or undesignated (economic) hedge relationships.
The Company is exposed to credit risk in the event of nonperformance of counterparties for foreign currency forward exchange contracts and interest rate swaps. We monitor our exposure to credit risk by using major global banks and financial institutions as counterparties and monitoring their financial condition and credit profile. The Company does not anticipate nonperformance by any of these counterparties, and therefore, recording a valuation allowance against the Company’s derivative balance is not considered necessary.
Derivative Positions Summary
Certain of the Company’s derivative transactions are subject to master netting arrangements that allow the Company to settle with the same counterparties. These arrangements generally do not call for collateral and as of the applicable dates presented in the following table, no cash collateral had been received or pledged related to the underlying derivatives. We have elected to present our derivative balances on a gross basis on the condensed consolidated balance sheet.
The following table summarizes the gross fair value of the Company’s outstanding derivatives and the lines in which they are presented on the condensed consolidated balance sheet.
Derivative Assets | Derivative Liabilities | ||||||||||||||||||||||
(in thousands) | June 30, 2022 | December 31, 2021 | June 30, 2022 | December 31, 2021 | |||||||||||||||||||
Prepaid expenses and other current assets | $ | 3,815 | $ | 4,081 | $ | — | $ | — | |||||||||||||||
Accrued expenses and other current liabilities | — | — | 4,300 | 3,773 | |||||||||||||||||||
Other long-term liabilities | — | — | 3,535 | — | |||||||||||||||||||
$ | 3,815 | $ | 4,081 | $ | 7,835 | $ | 3,773 |
The following table summarizes the notional values of the Company’s outstanding derivatives:
(in thousands) | June 30, 2022 | December 31, 2021 | |||||||||
Notional value of foreign currency forward contracts and interest rate swaps | $ | 912,688 | $ | 704,190 |
Cash Flow Hedges
The Company utilizes foreign currency forward contracts to hedge the effect of foreign currency exchange rate fluctuations on forecasted foreign currency transactions, primarily related to inventory purchases. These forward contracts are designated as cash flow hedges. The changes in fair value of these contracts attributable to changes in spot exchange rates are recorded in AOCI until the hedged items affect earnings, at which time the gain or loss is reclassified into the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged. The forward points are marked-to-market monthly and recognized in the same line item in the condensed consolidated statements of income (loss) as the underlying exposure being hedged.
Under interest rate swaps, we agree with other parties to exchange, at specified intervals, the difference between fixed-rate and floating-rate interest amounts calculated by reference to an agreed notional principal amount. We pay a floating rate and receive a fixed rate under these agreements. Any unrealized gain or loss at the time of settlement will be reclassified and reduce net interest expense as we record interest expense on the associated debt.
21
Derivatives Not Designated as Hedging Instruments
The Company also uses foreign currency forward contracts to offset its exposure to the change in value of certain foreign currency denominated assets and liabilities, primarily receivables and payables, which are remeasured at the end of each period. Although the contracts are effective economic hedges, they are not designated as accounting hedges. Therefore, changes in the value of these derivatives are recognized immediately in earnings, thereby offsetting the current earnings effect of the related foreign currency denominated assets and liabilities.
Effect of Derivative Instruments on Income
The loss of all derivative instruments recognized is summarized below:
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
(in thousands) | 2022 | 2021 | 2022 | 2021 | |||||||||||||||||||
Loss reclassified from AOCI to income on cash flow hedges: | |||||||||||||||||||||||
Cost of goods and services | $ | (118) | $ | 1,018 | $ | (47) | $ | 1,772 | |||||||||||||||
Loss on derivatives not designated as hedging instruments: | |||||||||||||||||||||||
Other (income) expense, net | 1,251 | 795 | 5,411 | 1,462 | |||||||||||||||||||
Total loss of derivative instruments | $ | 1,133 | $ | 1,813 | $ | 5,364 | $ | 3,234 |
NOTE 14—INVENTORIES
Inventories consisted of the following:
(in thousands) | June 30, 2022 | December 31, 2021 | |||||||||
Raw materials | $ | 224,508 | $ | 186,516 | |||||||
Work in progress | 20,803 | 13,615 | |||||||||
Finished goods | 485,089 | 421,702 | |||||||||
730,400 | 621,833 | ||||||||||
Inventory reserve | (27,545) | (24,646) | |||||||||
LIFO adjustments (1) | (95,899) | (54,277) | |||||||||
Inventories, net | $ | 606,956 | $ | 542,910 |
(1) Represents the amount by which the current cost of LIFO inventories exceeded their carrying value.
22
NOTE 15—CASH FLOW INFORMATION
Leased Asset Program
Our electrical submersible pumping (“ESP”) leased asset program is reported in our Production & Automation Technologies segment. At the time of purchase, assets are recorded to inventory and are transferred to property, plant, and equipment when a customer contracts for an asset under our leased asset program. During the six months ended June 30, 2022 and June 30, 2021, we transferred $34.7 million and $20.3 million, respectively, of inventory into property, plant, and equipment as a result of assets entering our leased asset program.
Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our leased asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.
23
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Management’s discussion and analysis is our analysis of our financial performance, financial condition and significant trends that may affect our future performance. It should be read in conjunction with the condensed consolidated financial statements, and notes thereto, included elsewhere in this report. It contains forward-looking statements including, without limitation, statements relating to ChampionX’s plans, strategies, objectives, expectations and intentions that are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are often identified by the words “believe,” “anticipate,” “expect,” “may,” “intend,” “foresee,” “guidance,” “estimate,” “potential,” “outlook,” “plan,” “should,” “would,” “could,” “target,” “forecast” and similar expressions, including the negative thereof. We undertake no obligation to publicly update, revise or correct any of our forward-looking statements after the date they are made, whether as a result of new information, future events or otherwise, except to the extent required under the federal securities laws. Readers are cautioned that such forward-looking statements should be read in conjunction with the disclosures under the heading “CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS.”
EXECUTIVE OVERVIEW AND BUSINESS OUTLOOK
We are a global leader in chemistry solutions and highly engineered equipment and technologies that help companies drill for and produce oil and gas safely, efficiently and sustainably around the world. Our products provide efficient and safe operations throughout the lifecycle of a well with a focus on the production phase of wells. Our business is organized into four reportable segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies. We refer to the Production Chemical Technologies segment and Reservoir Chemical Technologies segment together as the Chemical Technologies business.
Recent Events
Russia’s invasion of Ukraine and the related sanctions imposed present economic risk to companies that engage in business within, or have economic ties to, Russia. Our Russia operations (the “CT Russia Business”) are fully contained within the country and include service operations, a manufacturing plant and related inventory, an established customer base and local employees, and has the ability to operate as a standalone business under the brand, Master Chemicals. The revenues, net income and total assets of the CT Russia Business represent less than 2% of our consolidated results of operations. Given the continued economic pressure and sanctions imposed by the United States, European Union and United Kingdom, during the second quarter of 2022, we initiated a plan to dispose of our CT Russia Business. As a result, the CT Russia Business met the criteria to be reported as held for sale and, therefore, was reflected in our condensed consolidated balance sheet as of June 30, 2022 at the lower of its carrying value or its fair value less costs to sell (“estimated selling price”). We recorded a charge of $22.9 million for the three and six months ended June 30, 2022, representing the amount by which the carrying amount exceeded the estimated selling price. Upon the ultimate disposition, we will recognize the accumulated cumulative translation adjustment balance associated with the CT Russia Business in our condensed consolidated statement of income as part of the gain or loss on the sale.
On June 7, 2022, we entered into a restated credit agreement (the “Restated Credit Agreement”), which amends and restates the Credit Agreement dated as of May 9, 2018 (the “2018 Credit Agreement”). The Restated Credit Agreement provides for (i) a $625 million 7-year senior secured term loan B facility (the “2022 Term Loan Facility”) and (ii) a five-year senior secured revolving credit facility in an aggregate principal amount of $700 million, of which $100 million is available for the issuance of letters of credit (the “2022 Revolving Credit Facility,” together with the 2022 Term Loan Facility, the “Senior Secured Credit Facility”). The full amount of the 2022 Term Loan Facility was funded, and $135 million of the 2022 Revolving Credit Facility was drawn, on June 7, 2022, with the aggregate proceeds used to repay outstanding amounts under our 2018 Credit Agreement, repay and terminate the Credit Agreement dated June 3, 2020, and to redeem all outstanding 6.375% Senior Notes due 2026. Proceeds from future borrowings under the 2022 Revolving Credit Facility are expected to be used for working capital and general corporate purposes. The 2022 Term Loan Facility matures June 7, 2029 and the 2022 Revolving Credit Facility matures June 7, 2027. The 2022 Term Loan Facility is subject to mandatory amortization payments of 1% per annum of the initial commitment paid quarterly, which begins on December 31, 2022.
Business Environment
We monitor macro-economic conditions and industry-specific drivers and key risk factors affecting our business segments as we formulate our strategic plans and make decisions related to allocating capital and human resources. Our business segments provide a broad range of technologies and products to support oil and gas production, exploration and development, and the midstream sector. As a result, we are substantially dependent upon global oil production levels, as well as new investment activity levels in the oil and gas and midstream sectors. Demand for our products, technologies and services is impacted by
24
overall global demand for oil and gas, ongoing depletion rates of existing oil and gas wells, and our customers’ willingness to invest in the exploration for and development of new oil and gas resources. Our customers determine their operating and capital budgets based on current and expected future crude oil and natural gas prices, United States (“U.S.”) and worldwide rig count, U.S. well completions and expectation of industry cost levels, among other factors. Crude oil and natural gas prices are impacted by supply and demand, which are influenced by geopolitical, macroeconomic, and local events, and have historically been subject to substantial volatility and cyclicality. Rig count, footage drilled, and exploration and production (“E&P”) investment by oil and gas operators have often been used as leading indicators for the level of drilling and development activity and future production levels in the oil and gas sector.
Market Conditions and Outlook
Oil prices steadily increased throughout 2021 and into the first half of 2022, reaching a 13-year high, due in part to the global economy reopening following the COVID pandemic and supply side constraints. During July 2022, oil prices softened in response to some indications of slowing global economic growth, which could reduce energy demand; although oil prices continue to be significantly higher year-over-year.
The Russian invasion of Ukraine in February 2022, resulted in significant U.S., European Union, and United Kingdom sanctions on Russia and the announced exit of certain international oil companies from Russian operations. The U.S. and European Union sanctioned the importation of Russian crude oil, which reduced Russia’s oil revenues and put additional upward pressure and volatility on oil prices. Although oil production is still below pre-pandemic levels as many publicly traded oil and gas companies focus on debt reduction and capital return to shareholders rather than increasing output.
We have seen a steady increase in U.S. oil and gas rig counts and some uptick in international activity. However, we have also experienced supply chain disruptions, due at least in part to the ongoing COVID-19 pandemic worldwide, the invasion of Ukraine, and logistic challenges globally. The U.S. inflation rate is the highest experienced in four decades, primarily as a result of supply chain constraints and partially attributed to the rising oil and natural gas prices, which is a major economic input. The global economy reopening has also contributed to general inflationary pressures. We continue to work diligently to deliver price increases to offset the impact of raw material, labor and logistics-related inflation that we have experienced in our businesses. We expect to continue to face inflationary pressure throughout the remainder of 2022.
CRITICAL ACCOUNTING ESTIMATES
Refer to our “Critical Accounting Estimates” included in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2021 for a discussion of our critical accounting estimates.
CONSOLIDATED RESULTS OF OPERATIONS
Three Months Ended | |||||||||||||||||
June 30, | March 31, | Variance | |||||||||||||||
(in thousands) | 2022 | 2022 | $ | ||||||||||||||
Revenue | $ | 932,572 | $ | 865,960 | $ | 66,612 | |||||||||||
Cost of goods and services | 720,684 | 658,350 | 62,334 | ||||||||||||||
Gross profit | 211,888 | 207,610 | 4,278 | ||||||||||||||
Selling, general and administrative expense | 141,351 | 150,360 | (9,009) | ||||||||||||||
Interest expense, net | 10,765 | 11,363 | (598) | ||||||||||||||
Other (income) expense, net | 32,281 | 1,320 | 30,961 | ||||||||||||||
Income before income taxes | 27,491 | 44,567 | (17,076) | ||||||||||||||
Provision for income taxes | (1,405) | 6,394 | (7,799) | ||||||||||||||
Net income | 28,896 | 38,173 | (9,277) | ||||||||||||||
Net income attributable to noncontrolling interest | 1,554 | 1,471 | 83 | ||||||||||||||
Net income attributable to ChampionX | $ | 27,342 | $ | 36,702 | $ | (9,360) |
Revenue. Revenue increased $66.6 million, or 8%, sequentially, with improvement across all operating segments. The increase is attributable to demand growth within the U.S. as well as internationally, as we rebound from the normal first quarter seasonality in our business. This growth is due in part to increased land-based rig count and associated increases in customer spending on drilling activities as well as market expansion. Additionally, increased global pricing was implemented to mitigate the increase in costs for raw materials and other inflationary factors.
25
Gross profit. Gross profit increased $4.3 million, or 2%, due to the increase in volume and price noted above, mostly offset by inflation in our raw material and logistic costs.
Selling, general and administrative expense. Selling, general and administrative expense decreased $9.0 million, or 6%, sequentially primarily due to the reduction in restructuring charges relating to employee severance and related benefits incurred during the three months ended March 31, 2022.
Other (income) expense, net. Other (income) expense, net increased $31.0 million, primarily due to a charge of $22.9 million in connection with reclassifying our CT Russia Business to held for sale during the second quarter of 2022.
Provision for income taxes. Our provision for income taxes reflected effective tax rates of (5.1)% and 14.3% for the three months ended June 30, 2022 and March 31, 2022, respectively. The effective tax rate for both periods was impacted by favorable adjustments relating to prior period tax return filings. The period ending June 30, 2022 was further impacted by the release of a valuation allowance on our operations in Angola, and a charge incurred on our CT Russia Business upon classifying as held for sale.
CONSOLIDATED RESULTS OF OPERATIONS
Six Months Ended | |||||||||||||||||
June 30, | Variance | ||||||||||||||||
(in thousands) | 2022 | 2021 | $ | ||||||||||||||
Revenue | $ | 1,798,532 | $ | 1,434,060 | $ | 364,472 | |||||||||||
Cost of goods and services | 1,379,034 | 1,091,723 | 287,311 | ||||||||||||||
Gross profit | 419,498 | 342,337 | 77,161 | ||||||||||||||
Selling, general and administrative expense | 291,711 | 295,819 | (4,108) | ||||||||||||||
Interest expense, net | 22,128 | 28,035 | (5,907) | ||||||||||||||
Other (income) expense, net | 33,601 | 315 | 33,286 | ||||||||||||||
Income before income taxes | 72,058 | 18,168 | 53,890 | ||||||||||||||
Provision for income taxes | 4,989 | 6,345 | (1,356) | ||||||||||||||
Net income | 67,069 | 11,823 | 55,246 | ||||||||||||||
Net income (loss) attributable to noncontrolling interest | 3,025 | (1,199) | 4,224 | ||||||||||||||
Net income attributable to ChampionX | $ | 64,044 | $ | 13,022 | 51,022 | ||||||||||||
Revenue. Revenue increased $364.5 million, or 25%, for the six months ended June 30, 2022 compared to prior year driven by higher volumes in North America and internationally as the global economy has rebounded from the COVID-19 pandemic and rig counts and customer activity has increased. This was further supplemented by the realization of price increases initiated to offset raw material and logistic costs inflation.
Gross profit. Gross profit increased $77.2 million, or 23%, for the six months ended June 30, 2022 compared to prior year, mainly due to the incremental volumes and pricing noted above.
Selling, general and administrative expense. Selling, general and administrative expense decreased $4.1 million, or 1%, for the six months ended June 30, 2022 compared to prior year, primarily due to fewer integration related costs associated with the acquisition of the Chemical Technologies business as well as various cost reduction initiatives.
Interest expense, net. Interest expense, net decreased $5.9 million, or 21%, for the six months ended June 30, 2022 compared to prior year primarily due to the redemption of our 6.375% Senior Notes due 2026.
Other (income) expense, net. Other (income) expense, net increased $33.3 million, primarily due to a charge of $22.9 million in connection with reclassifying our CT Russia Business to held for sale during the second quarter of 2022.
Provision for (benefit from) income taxes. The effective tax rates for the first six months of 2022 and 2021 were 6.9% and 34.9%, respectively. The effective tax rate for the first six months of 2022 was positively impacted by the release of the valuation allowance on our operations in Angola, a charge incurred on the CT Russia Business upon classifying to held for sale, and the recognition of adjustments in several foreign jurisdictions relating to income tax return filings that had a positive impact on the rate. The effective tax rate for the first six months of 2021 was negatively affected primarily due to the impact of withholding taxes.
26
SEGMENT RESULTS OF OPERATIONS
Three Months Ended | |||||||||||||||||
June 30, | March 31, | Variance | |||||||||||||||
(in thousands) | 2022 | 2022 | $ | ||||||||||||||
Segment revenue: | |||||||||||||||||
Production Chemical Technologies | $ | 552,411 | $ | 514,972 | $ | 37,439 | |||||||||||
Production & Automation Technologies | 242,399 | 220,349 | 22,050 | ||||||||||||||
Drilling Technologies | 57,858 | 56,859 | 999 | ||||||||||||||
Reservoir Chemical Technologies | 44,114 | 39,900 | 4,214 | ||||||||||||||
Corporate and other | 35,790 | 33,880 | 1,910 | ||||||||||||||
Total revenue | $ | 932,572 | $ | 865,960 | $ | 66,612 | |||||||||||
Segment operating profit (loss): | |||||||||||||||||
Production Chemical Technologies | $ | 25,606 | $ | 31,263 | $ | (5,657) | |||||||||||
Production & Automation Technologies | 23,650 | 24,710 | (1,060) | ||||||||||||||
Drilling Technologies | 15,043 | 15,220 | (177) | ||||||||||||||
Reservoir Chemical Technologies | (8,147) | (3,469) | (4,678) | ||||||||||||||
Total segment operating profit | 56,152 | 67,724 | (11,572) | ||||||||||||||
Corporate expense and other | 17,896 | 11,794 | 6,102 | ||||||||||||||
Interest expense, net | 10,765 | 11,363 | (598) | ||||||||||||||
Income before income taxes | $ | 27,491 | $ | 44,567 | $ | (17,076) |
Production Chemical Technologies
Revenue. Production Chemical Technologies revenue increased $37.4 million, or 7%, sequentially, mainly due to increased global pricing, which was implemented to help offset the increase in costs for raw materials and other inflationary factors, and to a lesser extent higher volumes both in the U.S. and internationally.
Operating profit. Production Chemical Technologies operating profit decreased $5.7 million in the second quarter of 2022 compared to the prior quarter primarily due to a charge of $22.9 million to reduce the carrying value of the CT Russia Business to its estimated fair value as we classified that business as held for sale during the period.
Production & Automation Technologies
Revenue. Production & Automation Technologies revenue increased $22.1 million, or 10%, as compared to the prior quarter, primarily due to an increase in customer spending, market share expansion and price increases to mitigate raw material inflation. Customer spending was driven by the strong market recovery, which led to higher volumes across our product offerings in North America and internationally.
Operating profit. Production & Automation Technologies operating profit decreased $1.1 million in the second quarter of 2022 compared to the prior quarter primarily due to a $5.3 million gain recognized during the previous quarter related to the sale of facilities. Absent the gain, this segment benefited from increased global pricing and higher sales volume noted above, partially offset by the impact of material cost inflation and supply chain disruptions.
Drilling Technologies
Revenue. Drilling Technologies revenue increased $1.0 million, or 2%, in the second quarter of 2022 compared to the prior quarter primarily due to an increase in sales volumes of our diamond cutters and diamond bearings products.
Operating profit. Drilling Technologies operating profit decreased $0.2 million in the second quarter of 2022 compared to the prior quarter primarily due to material cost inflation and incremental production costs incurred during the period, partially offset by higher sales volume as noted above.
27
Reservoir Chemical Technologies
Revenue. Reservoir Chemical Technologies revenue increased $4.2 million, or 11%, in the second quarter of 2022 compared to the prior quarter primarily due to the realization of price increases initiated to offset material cost inflation as well as an increase in volumes.
Operating profit. Reservoir Chemical Technologies operating profit decreased $4.7 million in the second quarter of 2022 compared to the prior quarter. Although we have seen a positive impact in revenue due to our global price increase initiatives, this is more than offset by continued raw materials and inflationary pressure. Additionally, this segment was impacted by approximately $5.4 million in restructuring charges incurred during the second quarter of 2022 as we exit certain product lines to improve the overall profitability of this business.
Six Months Ended June 30, | Variance | ||||||||||||||||
(in thousands) | 2022 | 2021 | $ | ||||||||||||||
Segment revenue: | |||||||||||||||||
Production Chemical Technologies | $ | 1,067,383 | $ | 859,420 | $ | 207,963 | |||||||||||
Production & Automation Technologies | 462,748 | 355,018 | 107,730 | ||||||||||||||
Drilling Technologies | 114,717 | 72,583 | 42,134 | ||||||||||||||
Reservoir Chemical Technologies | 84,014 | 63,113 | 20,901 | ||||||||||||||
Corporate | 69,670 | 83,926 | (14,256) | ||||||||||||||
Total revenue | $ | 1,798,532 | $ | 1,434,060 | $ | 364,472 | |||||||||||
Segment operating profit (loss): | |||||||||||||||||
Production Chemical Technologies | $ | 56,869 | $ | 64,228 | $ | (7,359) | |||||||||||
Production & Automation Technologies | 48,360 | 17,654 | 30,706 | ||||||||||||||
Drilling Technologies | 30,263 | 10,254 | 20,009 | ||||||||||||||
Reservoir Chemical Technologies | (11,616) | (5,822) | (5,794) | ||||||||||||||
Total segment operating profit | 123,876 | 86,314 | 37,562 | ||||||||||||||
Corporate expense and other | 29,690 | 40,111 | (10,421) | ||||||||||||||
Interest expense, net | 22,128 | 28,035 | (5,907) | ||||||||||||||
Income before income taxes | $ | 72,058 | $ | 18,168 | $ | 53,890 |
Production Chemical Technologies
Revenue. Production Chemical Technologies revenue increased $208.0 million, or 24%, as compared to the prior year, mainly due to higher volumes in our international operations as well as continued sales increases in North America. Additionally, increased global pricing was implemented to help partially offset the increase in costs for raw materials and other inflationary factors.
Operating profit. Production Chemical Technologies operating profit decreased $7.4 million compared to the prior year. Although this segment benefited from the higher revenue noted above, the increase was more than offset by a charge of $22.9 million related to the CT Russia Business, $12.0 million in restructuring charges and the impact of raw materials inflation.
Production & Automation Technologies
Revenue. Revenue increased $107.7 million, or 30%, as compared to the prior year, primarily due to an increase in customer spending as a result of improving market conditions. The increase in customer spending led to higher volumes across our product offerings in North America. The segment also benefited from the implementation of price increases to offset inflationary pressures in raw material and logistic costs.
Operating profit. Operating profit increased $30.7 million compared to the prior year primarily due to higher sales volumes and price as noted above. However, our results were negatively impacted by further material cost inflation and supply chain disruptions.
28
Drilling Technologies
Revenue. Revenue increased $42.1 million, or 58%, compared to the prior year primarily due to an increase in U.S. land-based rig count and associated increase in customer spending on drilling activities, which positively impacted sales volumes of our diamond cutters and diamond bearings products.
Operating profit. Operating profit increased $20.0 million compared to the prior year as a result of increased revenue.
Reservoir Chemical Technologies
Revenue. Revenue increased $20.9 million, or 33%, compared to the prior year primarily due to an increase in U.S. rig count and the realization of price increases initiated to offset material cost inflation, which more than offset the decline internationally.
Operating profit. Operating profit decreased $5.8 million compared to the prior year. Although we have seen a positive impact in revenue due to our global price increase initiatives, this is more than offset by continued raw materials and inflationary pressure. Additionally, this segment was impacted by approximately $5.4 million in restructuring charges incurred during the second quarter of 2022 as we exit certain product lines to improve the overall profitability of this business.
CAPITAL RESOURCES AND LIQUIDITY
Overview
Our primary source of cash is from operating activities. With the exception of the first quarter of 2022, we have historically generated, and expect to continue to generate, positive cash flow from operations. Cash generated from operations is generally allocated to working capital requirements, investments to support profitable revenue growth and maintain our facilities and systems, acquisitions that create value through add-on capabilities that broaden our existing businesses and deliver our growth strategy, as well as share repurchases, dividend payments to stockholders, and debt repayments to reduce our leverage.
At June 30, 2022, we had cash and cash equivalents of $167.3 million compared to $251.7 million at December 31, 2021, primarily for working capital and operational purposes. At June 30, 2022, we had total liquidity of $739.7 million, comprised of $167.3 million of cash and $572.4 million of available capacity on the 2022 Revolving Credit Facility, which expires in June 2027.
At June 30, 2022, we had a long-term debt balance of $694.4 million, net of the current portion of long-term debt of $4.7 million, primarily consisting of the 2022 Term Loan Facility with a principal amount of $625.0 million and an outstanding balance on the 2022 Revolving Credit Facility of $96.2 million.
Outlook
We expect to generate cash to support liquidity and business requirements through operations and, if necessary, through the 2022 Revolving Credit Facility. Volatility in credit, equity and commodity markets can create uncertainty for our businesses. However, the Company believes, based on our current financial condition and current expectations of future market conditions, that we will meet our short- and long-term needs with a combination of cash on hand, cash generated from operations, the 2022 Revolving Credit Facility and access to capital markets.
On February 4, 2022, our Board declared a cash dividend of $0.075 per share of common stock. This quarterly cash dividend was paid on April 29, 2022 to stockholders of record on April 8, 2022. On May 12, 2022, our Board declared a cash dividend of $0.075 per share of common stock. This quarterly cash dividend will be paid on July 29, 2022 to stockholders of record on July 1, 2022. Subsequent dividend declarations, if any, including the amounts and timing of future dividends, are subject to approval by the Board and will depend on future business conditions, financial conditions, results of operations and other factors.
29
On March 7, 2022, the Company announced that our Board approved a new $250 million share repurchase program (“2022 Share Repurchase Program”). Under the 2022 Share Repurchase Program, shares of the Company’s common stock may be repurchased periodically, including in the open market or privately negotiated transactions. We expect to fund share repurchases from cash generated from operations. As of June 30, 2022, we have repurchased 789,516 shares of common stock at an average price of $25.33 per share for a total of $20.0 million. The actual timing, manner, number, and value of shares repurchased under the program will depend on a number of factors, including the availability of excess free cash, the market price of the Company’s common stock, general market and economic conditions, applicable requirements, and other business considerations.
In 2022, we expect to fund our capital expenditures and reduce outstanding debt through earnings and working capital improvements. We project capital expenditures of 3.0% to 3.5% of revenue inclusive of capital investments for our electric submersible pump leased assets.
Information related to guarantees is incorporated herein by reference from Note 6—Commitments and Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
Cash Flows
Six Months Ended June 30, | |||||||||||
(in thousands) | 2022 | 2021 | |||||||||
Cash provided by operating activities | $ | 31,115 | $ | 151,138 | |||||||
Cash used in investing activities | (41,807) | (43,198) | |||||||||
Cash used in financing activities | (74,363) | (69,743) | |||||||||
Effect of exchange rate changes on cash and cash equivalents and restricted cash | 659 | (623) | |||||||||
Net increase (decrease) in cash and cash equivalents and restricted cash | $ | (84,396) | $ | 37,574 |
Operating Activities
Cash provided by operating activities during the six months ended June 30, 2022 decreased $120.0 million compared to 2021. The decrease in cash provided by operating activities was primarily driven by the use of cash for working capital items. Changes in working capital items used cash of $158.8 million during the six months ended June 30, 2022 compared to cash used of $7.5 million during 2021. The change in working capital items primarily related to cash outflows for inventory procurement and an increase in accounts receivable as a result of revenue growth during the period.
Expenditures for assets that are placed into our leased asset program expected to be recovered through sale are reported in leased assets in the operating section of our condensed consolidated statements of cash flows. All other capitalizable expenditures for assets that are placed into our leased asset program are classified as capital expenditures in the investing section of our condensed consolidated statements of cash flows.
Investing Activities
Cash used in investing activities was $41.8 million for the six months ended June 30, 2022, and was primarily comprised of capital expenditures of $53.6 million and acquisitions, net of cash acquired, of $3.2 million, partially offset by $14.9 million of cash proceeds from the sale of fixed assets primarily due to the sale of facilities within our Production & Automation Technologies segment.
Cash used in investing activities was $43.2 million for the six months ended June 30, 2021, and was primarily comprised of capital expenditures of $45.7 million, partially offset by $2.5 million of cash proceeds from the sale of fixed assets.
Financing Activities
Cash used in financing activities of $74.4 million for the six months ended June 30, 2022 was primarily the result of net repayments totaling $25.1 million on long-term debt as part of our refinancing, repurchases of our common stock of $20.0 million, dividends paid of $15.5 million, payment of debt issuance cost of $8.0 million, payments related to taxes withheld on stock-based compensation of $3.4 million, and payments of finance lease obligations of $3.1 million. This was partially offset by $3.1 million in cash proceeds from the exercise of stock options.
30
Cash used in financing activities of $69.7 million for the six months ended June 30, 2021 was primarily the result of repayments totaling $71.1 million on long-term debt, payments totaling $2.6 million for finance lease obligations, payments related to taxes withheld on stock-based compensation of $1.8 million, and a distribution of $0.8 million to one of our non-controlling interests. This was partially offset by $6.5 million in cash proceeds from the exercise of stock options.
Revolving Credit Facility
A summary of the 2022 Revolving Credit Facility at June 30, 2022 was as follows:
(in millions) Description | Amount | Debt Outstanding | Letters of Credit | Unused Capacity | Maturity | ||||||||||||||||||||||||
Five-year revolving credit facility | $ | 700.0 | $ | 96.2 | $ | 31.4 | $ | 572.4 | June 2027 |
Additionally, we have letters of credit outside of the 2022 Revolving Credit Facility totaling approximately $1.5 million. As of June 30, 2022, we were in compliance with all restrictive covenants under the Senior Secured Credit Facility.
Accounts Receivable Facility
On June 28, 2022, we entered into an uncommitted accounts receivable purchase agreement with JPMorgan Chase Bank, N.A. (the “Accounts Receivable Facility”). Transfers under the Accounts Receivable Facility are accounted for as sales of receivables, resulting in the receivables being derecognized from our consolidated balance sheet. The purchaser assumes the credit risk at the time of sale and has the right at any time to assign, transfer, or participate any of its rights under the purchased receivables to another bank or financial institution.
The amount available for purchase under the Accounts Receivable Facility fluctuates over time based on the total amount of eligible receivables generated during the normal course of business. The maximum receivables that can be sold under the Accounts Receivable Facility is $160.0 million. As of June 30, 2022, there were no receivables sold.
RECENTLY ISSUED ACCOUNTING STANDARDS
See Note 1—Basis of Presentation and Summary of Significant Accounting Policies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We may be exposed to certain market risks arising from the use of financial instruments in the ordinary course of business. For quantitative and qualitative disclosures about market risk, see Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” in our Annual Report on Form 10-K for the year ended December 31, 2021. On June 29, 2022, the Company executed a five-year floating-to-fixed interest rate swap to hedge our exposure to increases in variable interest rates on the 2022 Term Loan Facility, see Note 5—Debt to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q. Our exposure to market risk has not materially changed since December 31, 2021.
ITEM 4. CONTROLS AND PROCEDURES
Our management, with the participation of our principal executive officer and principal financial officer, carried out an evaluation, pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of June 30, 2022.
There were no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
31
PART II — OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are involved in various pending or potential legal actions in the ordinary course of our business. Management is unable to predict the ultimate outcome of these actions because of the inherent uncertainty of litigation. However, management believes the most probable, ultimate resolution of these matters will not have a material adverse effect on our condensed consolidated financial position, results of operations or cash flows. See Note 6—Commitments and Contingencies to our condensed consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q.
ITEM 1A. RISK FACTORS
Other than the risk factors set forth below, there have not been material changes from the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021.
We could lose customers or generate lower revenue, operating profits and cash flows if there are significant increases in the cost of raw materials or if we are unable to obtain raw materials.
We purchase raw materials, sub-assemblies and components for use in manufacturing operations, which exposes us to volatility in prices for certain commodities. Significant price increases for these commodities could adversely affect our operating profits. Like others in our industry, in 2021 we faced, and continue to face, unprecedented inflation in raw materials cost. In addition to general inflationary pressures relating to the global economy reopening, adverse weather, such as the severe winter storm in Texas in the early months of 2021, may also result in raw materials supply chain disruptions, that can lead to short-term raw materials cost inflation. International conflicts or other geopolitical events, such as the continuing conflict between Russia and Ukraine, may also cause upward pressure on raw materials costs due to transportation disruptions, higher manufacturing costs, disruptions in supply chains and availability of raw materials, interruptions in manufacturing operation, and heightened inflation. While we will generally attempt to mitigate the impact of increased raw material prices by endeavoring to make strategic purchasing decisions, broadening our supplier base and passing along increased costs to customers, there may be a time delay between the increased raw material prices and the ability to increase the prices of our products. Additionally, we may be unable to increase the prices of products due to the terms of existing contracts, a competitor’s pricing pressure or other factors. The inability to obtain necessary raw materials on acceptable terms could affect our ability to meet customer commitments and satisfy demand for certain products. Certain of our product lines depend on a limited number of third-party suppliers and vendors. The ability of these third parties to deliver raw materials may be affected by events beyond our control. Public health threats, such as COVID-19, severe influenza and other highly communicable viruses or diseases, in addition to international conflicts or other geopolitical events could limit access to vendors and their facilities, or the ability to transport raw materials from our vendors, which would adversely affect our ability to obtain necessary raw materials for certain of our products or increase the costs of such materials. A significant price increase in or the unavailability of raw materials may result in a loss of customers and adversely impact our business, results of operations, financial condition and cash flows, and could result in asset impairments, including an impairment of the carrying value of our goodwill.
We are subject to information technology, cybersecurity and privacy risks.
We depend on various information technologies and other products and services to store and process business information and otherwise support our business activities. We also manufacture and sell hardware and software to provide monitoring, controls and optimization of customer critical assets in oil and gas production and distribution. In addition, certain of our customer offerings include digital components, such as remote monitoring of certain customer operations. We also provide services to maintain these systems. Additionally, our operations rely upon partners, suppliers and other third-party providers of information technology and other products and services. If any of these information technologies, products or services are damaged, cease to properly function, are breached due to employee error, malfeasance, system errors, or other vulnerabilities, or are subject to cybersecurity attacks, such as those involving unauthorized access, malicious software and/or other intrusions, we and our partners, suppliers or other third parties could experience: (i) production downtimes, (ii) operational delays, (iii) the compromising of confidential, proprietary or otherwise protected information, including personal and customer data, (iv) destruction, corruption, or theft of data, (v) security breaches, (vi) other manipulation, disruption, misappropriation or improper use of our systems or networks, (vii) hydrocarbon pollution from loss of containment, (viii) financial losses from remedial actions, (ix) loss of business or potential liability, (x) adverse media coverage, and (xi) legal claims or legal proceedings, including regulatory investigations and actions, and/or damage to our reputation. Increased risks of such attacks and disruptions also exist because of the continuing conflict between Russia and Ukraine. While we have not experienced a material breach of our information technologies and we attempt to mitigate these risks by employing a number of measures, including employee training, technical security controls and maintenance of backup and protective systems, the Company’s and our customers’, partners’, vendors’ and other third- parties’ systems, networks, products and services remain potentially vulnerable to known or unknown cybersecurity attacks and other threats, any of which could have a material adverse effect on our business, results of operations, financial condition and cash flows.
32
While we currently maintain cybersecurity insurance, such insurance may not be sufficient in type or amount to cover us against claims related to cybersecurity breaches or attacks, failures or other data security-related incidents, and we cannot be certain that cyber insurance will continue to be available to us on economically reasonable terms, or at all, or that an insurer will not deny coverage as to any future claim. The successful assertion of one or more large claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could materially and adversely affect our results of operations, cash flows, and financial condition.
Our operations could be adversely affected by global market and economic conditions in ways we may not be able to predict or control.
Concerns over global economic conditions, inflation, energy costs, geopolitical issues, supply chain disruptions, the availability and cost of credit, the worldwide COVID-19 pandemic, and the continuing conflict between Russia and Ukraine have contributed to increased economic uncertainty. An expansion or escalation of the Russian-Ukraine conflict or an economic slowdown or recession in the United States or in any other country that significantly affects the supply of or demand for oil or natural gas could negatively impact our operations and therefore adversely affect our results. Global economic conditions have a significant impact on oil and natural gas prices and any stagnation or deterioration in global economic conditions could result in less demand for our services and could cause our customers to reduce their planned spending on drilling and production activity. Adverse global economic conditions may cause our customers, vendors and/or suppliers to lose access to the financing necessary to sustain or increase their current level of operations, fulfill their commitments and/or fund future operations and obligations. Furthermore, challenging economic conditions may result in certain of our customers experiencing bankruptcy or otherwise becoming unable to pay vendors, including us. In the past, global economic conditions, and expectations for future global economic conditions, have sometimes experienced significant deterioration in a relatively short period of time and there can be no assurance that global economic conditions or expectations for future global economic conditions will recover in the near term or not quickly deteriorate again due to one or more factors. These conditions could have a material adverse effect on our business, financial condition and results of operations.
Our reputation, ability to do business and results of operations may be impaired by violations of U.S. and international laws and regulations regarding anti-bribery, trade control, trade sanctions, anti-corruption and similar laws.
Our operations require us to comply with a number of U.S. and international laws and regulations, including those relating to anti-corruption, anti-bribery, fair competition, export and import compliance, money laundering and data privacy. Our international operations are subject to the regulations imposed by the Foreign Corrupt Practices Act and the United Kingdom Bribery Act 2010 as well as anti-bribery and anti-corruption laws of various jurisdictions in which we operate. In response to the conflict between Russia and Ukraine beginning in February 2022, the U.S. and foreign governmental bodies in jurisdictions in which we operate have announced targeted sanctions and export control measures and have threatened additional sanctions and export control measures, which may result in counter-sanctions and other retaliatory measures and actions by Russia against U.S.-based companies and their employees (together “Russian Conflict Sanctions”). While we strive to maintain high ethical standards and robust internal controls, we cannot provide assurance that our internal controls and compliance systems will always protect us from acts committed by our employees, agents or business partners that would violate such U.S. or international laws or regulations. Any such violations of law or improper actions could subject us to civil or criminal investigations in the United States or other jurisdictions, could lead to substantial civil or criminal, monetary and non-monetary penalties and related shareholder lawsuits, could lead to increased costs of compliance and could damage our reputation, business, results of operations, financial condition and cash flows.
Tariffs, sanctions and other trade measures could adversely affect our results of operations, financial position and cash flows.
In 2020, the U.S. government continued to impose tariffs on steel and aluminum and a broad range of other products imported into the United States. In response to the tariffs imposed by the U.S. government, a number of jurisdictions, including the European Union, Canada, Mexico, India and China, announced tariffs on U.S. goods and services. These tariffs have increased our material input costs, and any further trade restrictions, retaliatory trade measures and additional tariffs could result in higher input costs for our products. The Russian Conflict Sanctions have and could in the future result in, among other things, severe or complete restrictions on exports to and other commerce and business dealings involving Russia, certain regions of Ukraine, and/or particular entities and individuals. The potential impact of such sanction programs and export control measures on our business is uncertain at the current time due to the fluid nature of the military conflict as it is unfolding. The potential impacts include supply chain and logistics disruptions, financial impacts including volatility in foreign exchange rates and interest rates, inflationary pressures on raw materials and energy, heightened cybersecurity threats and other restrictions. We may not be able to fully mitigate the impact of these increased costs or pass price increases on to our customers. While tariffs and other
33
retaliatory trade measures imposed by other countries on U.S. goods have not yet had a significant impact on our business or results of operations, we cannot predict further developments, and such existing or future tariffs could have a material adverse effect on our results of operations, financial position and cash flows.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table contains information about our purchases of our common stock during the three months ended June 30, 2022.
Period | Total Number of Shares Purchased | Average Price Paid Per Share (1) | Total Number of Shares Purchased as Part of a Publicly Announced Program (2) | Maximum Dollar Value of Shares that May Yet Be Purchased Under the Program (2) | ||||||||||
April 1-30, 2022 | — | $ | — | — | $ | — | ||||||||
May 1-31, 2022 | — | $ | — | — | $ | — | ||||||||
June 1-30, 2022 | 789,516 | $ | 25.33 | 789,516 | $ | 229,984,214 | ||||||||
Total | 789,516 | $ | 25.33 | 789,516 |
(1)Excluding fees, commissions, and expenses associated with the share repurchases.
(2)On March 7, 2022, the Company announced that our Board authorized the Company to repurchase up to $250 million of its common stock. This program has no time limit and does not obligate the Company to acquire any particular amount of shares of its common stock.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
Iran Threat Reduction and Syria Human Rights Act of 2012
Under the Iran Threat Reduction and Syria Human Rights Act of 2012, which added Section 13(r) of the Exchange Act, the Company is required to disclose in its periodic reports if it or any of its affiliates knowingly engaged in certain activities, transactions or dealings relating to Iran or with entities or individuals designated pursuant to certain Executive Orders. Disclosure is required even where the activities are conducted outside the U.S. by non-U.S. affiliates in compliance with applicable law, and even if the activities are not covered or prohibited by U.S. law.
As authorized by the U.S. Treasury’s Office of Foreign Assets Control (“OFAC”), a non-U.S. subsidiary of the Company which is part of our Chemical Technologies business completed sales of products used for process and water treatment applications in upstream oil and gas production related to the operation of and production from the Rhum gas field off the Scottish coast (“Rhum”) totaling $480,221 during the period from January 1, 2022 to June 30, 2022. The net profit before taxes associated with these sales for each period were nominal. Rhum is jointly owned by Serica Energy plc and Iranian Oil Company (U.K.) Limited. Our non-U.S. subsidiary intends to continue the Rhum-related activities, consistent with a specific license obtained from OFAC by its customers, and such activities may require additional disclosure pursuant to the above mentioned statute.
34
ITEM 6. EXHIBITS
Incorporated by Reference | ||||||||||||||||||||
Exhibit No. | Exhibit Description | Form | Exhibit No. | Filing Date | ||||||||||||||||
3.1 | 8-K | 3.1 | May 11, 2018 | |||||||||||||||||
3.2 | 8-K | 3.1 | June 4, 2020 | |||||||||||||||||
3.3 | 8-K | 3.2 | June 4, 2020 | |||||||||||||||||
10.1 | 8-K | 10.1 | June 8, 2022 | |||||||||||||||||
10.2 | 8-K | 10.1 | July 5, 2022 | |||||||||||||||||
10.3 | 8-K | 10.2 | July 5, 2022 | |||||||||||||||||
31.1* | ||||||||||||||||||||
31.2* | ||||||||||||||||||||
32.1** | ||||||||||||||||||||
32.2** | ||||||||||||||||||||
101.INS* | XBRL Instance Document | |||||||||||||||||||
101.SCH* | XBRL Taxonomy Extension Schema Document | |||||||||||||||||||
101.CAL* | XBRL Taxonomy Extension Calculation Linkbase Document | |||||||||||||||||||
101.DEF* | XBRL Taxonomy Extension Definition Linkbase Document | |||||||||||||||||||
101.LAB* | XBRL Taxonomy Extension Label Linkbase Document | |||||||||||||||||||
101.PRE* | XBRL Taxonomy Extension Presentation Linkbase Document | |||||||||||||||||||
104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||||||||||||||
* Filed herewith | ||||||||||||||||||||
** Furnished herewith | ||||||||||||||||||||
35
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CHAMPIONX CORPORATION | ||||||||
(Registrant) | ||||||||
/s/ ANTOINE MARCOS | ||||||||
Antoine Marcos | ||||||||
Vice President, Corporate Controller and Chief Accounting Officer | ||||||||
(Principal Accounting Officer and a Duly Authorized Officer) | ||||||||
Date: | July 27, 2022 |
36